<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Am Heart Assoc</journal-id><journal-id journal-id-type="iso-abbrev">J Am Heart Assoc</journal-id><journal-id journal-id-type="doi">10.1002/(ISSN)2047-9980</journal-id><journal-id journal-id-type="publisher-id">JAH3</journal-id><journal-id journal-id-type="hwp">ahaoa</journal-id><journal-title-group><journal-title>Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease</journal-title></journal-title-group><issn pub-type="epub">2047-9980</issn><publisher><publisher-name>John Wiley and Sons Inc.</publisher-name><publisher-loc>Hoboken</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">29066437</article-id><article-id pub-id-type="pmc">5721827</article-id><article-id pub-id-type="doi">10.1161/JAHA.117.005707</article-id><article-id pub-id-type="publisher-id">JAH32583</article-id><article-categories><subj-group subj-group-type="overline"><subject>Original Research</subject></subj-group><subj-group subj-group-type="heading"><subject>Original Research</subject><subj-group subj-group-type="heading"><subject>Epidemiology</subject></subj-group></subj-group></article-categories><title-group><article-title>Effects of Vitamin D on Blood Pressure, Arterial Stiffness, and Cardiac Function in Older People After 1&#x000a0;Year: BEST&#x02010;D (Biochemical Efficacy and Safety Trial of Vitamin D)</article-title><alt-title alt-title-type="left-running-head">Tomson et&#x000a0;al</alt-title></title-group><contrib-group><contrib id="jah32583-cr-0001" contrib-type="author"><name><surname>Tomson</surname><given-names>Joseph</given-names></name><degrees>MRCP</degrees><xref ref-type="aff" rid="jah32583-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="jah32583-cr-0002" contrib-type="author"><name><surname>Hin</surname><given-names>Harold</given-names></name><degrees>MRCP</degrees><xref ref-type="aff" rid="jah32583-aff-0003">
<sup>3</sup>
</xref></contrib><contrib id="jah32583-cr-0003" contrib-type="author"><name><surname>Emberson</surname><given-names>Jonathan</given-names></name><degrees>PhD</degrees><xref ref-type="aff" rid="jah32583-aff-0001">
<sup>1</sup>
</xref><xref ref-type="aff" rid="jah32583-aff-0002">
<sup>2</sup>
</xref></contrib><contrib id="jah32583-cr-0004" contrib-type="author"><name><surname>Kurien</surname><given-names>Rijo</given-names></name><degrees>MSc</degrees><xref ref-type="aff" rid="jah32583-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="jah32583-cr-0005" contrib-type="author"><name><surname>Lay</surname><given-names>Michael</given-names></name><degrees>DPhil</degrees><xref ref-type="aff" rid="jah32583-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="jah32583-cr-0006" contrib-type="author"><name><surname>Cox</surname><given-names>Jolyon</given-names></name><degrees>DPhil</degrees><xref ref-type="aff" rid="jah32583-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="jah32583-cr-0007" contrib-type="author"><name><surname>Hill</surname><given-names>Michael</given-names></name><degrees>DPhil</degrees><xref ref-type="aff" rid="jah32583-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="jah32583-cr-0008" contrib-type="author"><name><surname>Arnold</surname><given-names>Linda</given-names></name><degrees>MSc</degrees><xref ref-type="aff" rid="jah32583-aff-0004">
<sup>4</sup>
</xref></contrib><contrib id="jah32583-cr-0009" contrib-type="author"><name><surname>Leeson</surname><given-names>Paul</given-names></name><degrees>FRCP</degrees><xref ref-type="aff" rid="jah32583-aff-0004">
<sup>4</sup>
</xref></contrib><contrib id="jah32583-cr-0010" contrib-type="author"><name><surname>Armitage</surname><given-names>Jane</given-names></name><degrees>FRCP</degrees><xref ref-type="aff" rid="jah32583-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="jah32583-cr-0011" contrib-type="author" corresp="yes"><name><surname>Clarke</surname><given-names>Robert</given-names></name><degrees>FRCP</degrees><address><email>robert.clarke@ndph.ox.ac.uk</email></address><xref ref-type="aff" rid="jah32583-aff-0001">
<sup>1</sup>
</xref></contrib></contrib-group><aff id="jah32583-aff-0001">
<label><sup>1</sup></label>
<named-content content-type="organisation-division">Clinical Trial Service Unit and Epidemiological Studies Unit</named-content>
<named-content content-type="organisation-division">Nuffield Department of Population Health</named-content>
<institution>University of Oxford</institution>
<country country="GB">United Kingdom</country>
</aff><aff id="jah32583-aff-0002">
<label><sup>2</sup></label>
<named-content content-type="organisation-division">MRC Population Health Research Unit</named-content>
<named-content content-type="organisation-division">Nuffield Department of Population Health</named-content>
<institution>University of Oxford</institution>
<country country="GB">United Kingdom</country>
</aff><aff id="jah32583-aff-0003">
<label><sup>3</sup></label>
<institution>Hightown Surgery</institution>
<named-content content-type="city">Banbury</named-content>
<named-content content-type="country-part">Oxfordshire</named-content>
<country country="GB">United Kingdom</country>
</aff><aff id="jah32583-aff-0004">
<label><sup>4</sup></label>
<named-content content-type="organisation-division">Oxford Cardiovascular Clinical Research Facility</named-content>
<named-content content-type="organisation-division">Radcliffe Department of Medicine</named-content>
<institution>John Radcliffe Hospital</institution>
<named-content content-type="city">Oxford</named-content>
<country country="GB">United Kingdom</country>
</aff><author-notes><corresp id="correspondenceTo"><label>*</label><bold>Correspondence to:</bold> Robert Clarke, FRCP, Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Richard Doll Building, Old Road Campus, Oxford OX3 7LF, United Kingdom. E&#x02010;mail: <email>robert.clarke@ndph.ox.ac.uk</email></corresp></author-notes><pub-date pub-type="epub"><day>24</day><month>10</month><year>2017</year></pub-date><pub-date pub-type="collection"><month>10</month><year>2017</year></pub-date><volume>6</volume><issue>10</issue><issue-id pub-id-type="doi">10.1002/jah3.2017.6.issue-10</issue-id><elocation-id>e005707</elocation-id><history><date date-type="received"><day>26</day><month>1</month><year>2017</year></date><date date-type="accepted"><day>09</day><month>8</month><year>2017</year></date></history><permissions><!--<copyright-statement content-type="issue-copyright"> Copyright &#x000a9; 2017 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley Blackwell <copyright-statement>--><copyright-statement content-type="article-copyright">&#x000a9; 2017 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley.</copyright-statement><license license-type="creativeCommonsBy"><license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri content-type="pdf" xlink:type="simple" xlink:href="file:JAH3-6-e005707.pdf"/><abstract id="jah32583-abs-0001"><sec id="jah32583-sec-0001"><title>Background</title><p>The relevance of vitamin D for prevention of cardiovascular disease is uncertain. The <styled-content style="fixed-case">BEST</styled-content>&#x02010;D (Biochemical Efficacy and Safety Trial of vitamin D) trial previously reported effects of vitamin D on plasma markers of vitamin D status, and the present report describes the effects on blood pressure, heart rate, arterial stiffness, and cardiac function.</p></sec><sec id="jah32583-sec-0002"><title>Methods and Results</title><p>This was a randomized, double&#x02010;blind, placebo&#x02010;controlled trial of 305 older people living in United Kingdom, who were allocated vitamin D 4000&#x000a0;IU (100&#x000a0;&#x003bc;g), vitamin D 2000&#x000a0;IU (50&#x000a0;&#x003bc;g), or placebo daily. Primary outcomes were plasma concentrations of 25&#x02010;hydroxy&#x02010;vitamin D and secondary outcomes were blood pressure, heart rate, and arterial stiffness in all participants at 6 and 12&#x000a0;months, plasma N&#x02010;terminal prohormone of brain natriuretic peptide levels in all participants at 12&#x000a0;months, and echocardiographic measures of cardiac function in a randomly selected subset (n=177) at 12&#x000a0;months. Mean (<styled-content style="fixed-case">SE</styled-content>) plasma 25&#x02010;hydroxy&#x02010;vitamin D concentrations were 50 (<styled-content style="fixed-case">SE</styled-content> 2) nmol/L at baseline and increased to 137 (2.4), 102 (2.4), and 53 (2.4) nmol/L after 12&#x000a0;months in those allocated 4000&#x000a0;IU/d, 2000&#x000a0;IU/d of vitamin D, or placebo, respectively. Allocation to vitamin D had no significant effect on mean levels of blood pressure, heart rate, or arterial stiffness at either 6 or 12&#x000a0;months, nor on any echocardiographic measures of cardiac function, or plasma N&#x02010;terminal prohormone of brain natriuretic peptide concentration at 12&#x000a0;months.</p></sec><sec id="jah32583-sec-0003"><title>Conclusions</title><p>The absence of any significant effect of vitamin D on blood pressure, arterial stiffness, or cardiac function suggests&#x000a0;that any beneficial effects of vitamin D on cardiovascular disease are unlikely to be mediated through these mechanisms.</p></sec><sec id="jah32583-sec-0004"><title>Clinical Trial Registration</title><p>
<styled-content style="fixed-case">URL</styled-content>: <ext-link ext-link-type="uri" xlink:href="https://www.clinicaltrialsregister.eu/ctr-search/search">https://www.clinicaltrialsregister.eu/ctr-search/search</ext-link>. Unique identifier: EudraCT number: 2011&#x02013;005763&#x02010;24a</p></sec></abstract><kwd-group kwd-group-type="author-generated"><kwd id="jah32583-kwd-0001">blood pressure</kwd><kwd id="jah32583-kwd-0002">cardiac dysfunction</kwd><kwd id="jah32583-kwd-0003">vitamin D</kwd></kwd-group><kwd-group kwd-group-type="subject-categories"><title>Subject Categories</title><kwd>Cardiovascular Disease</kwd><kwd>Epidemiology</kwd><kwd>Aging</kwd></kwd-group><funding-group><award-group><funding-source>British Heart Foundation</funding-source></award-group><award-group><funding-source>University of Oxford</funding-source></award-group></funding-group><counts><fig-count count="2"/><table-count count="5"/><page-count count="9"/><word-count count="7142"/></counts><custom-meta-group><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>component-id</meta-name><meta-value>jah32583</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>October 2017</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_NLMPMC version:5.2.1 mode:remove_FC converted:24.10.2017</meta-value></custom-meta></custom-meta-group></article-meta><notes><p content-type="self-citation">
<mixed-citation publication-type="journal" id="jah32583-cit-1001">(<source>J Am Heart Assoc</source>. <year>2017</year>;<volume>6</volume>:<elocation-id>e005707</elocation-id> DOI: <ext-link ext-link-type="doi" xlink:href="10.1161/JAHA.117.005707">10.1161/JAHA.117.005707</ext-link>.)<pub-id pub-id-type="pmid">29066437</pub-id></mixed-citation>
</p></notes></front><body><p>
<boxed-text position="anchor" content-type="box" id="jah32583-blkfxd-0001" orientation="portrait"><sec id="jah32583-sec-0006"><title>Clinical Perspective</title><sec id="jah32583-sec-0007"><title>What Is New?</title><p>
<list list-type="bullet" id="jah32583-list-0001"><list-item><p>This randomized trial of 305 community&#x02010;dwelling older people demonstrated that supplementation with high&#x02010;dose vitamin D compared with placebo for 12&#x000a0;months had no significant effect on blood pressure, arterial stiffness, echocardiographic measures of cardiac function, or on biochemical markers of cardiac function.</p></list-item></list>
</p></sec><sec id="jah32583-sec-0008"><title>What Are the Clinical Implications?</title><p>
<list list-type="bullet" id="jah32583-list-0002"><list-item><p>Pending the results of ongoing large trials of vitamin D for the prevention of fracture and other disease outcomes, the absence of any significant effects of vitamin D on blood pressure, arterial stiffness, or cardiac function observed in the present study provides no support for use of vitamin D supplements for the prevention of cardiovascular disease.</p></list-item></list>
</p></sec></sec></boxed-text>
</p><sec id="jah32583-sec-0009"><title>Introduction</title><p>Prospective studies have reported inverse associations of plasma concentrations of 25&#x02010;hydroxy&#x02010;vitamin D (25[OH]D) with the risk of all&#x02010;cause and cardiovascular disease (CVD) mortality with an approximately linear association on a logarithmic scale up to &#x02248;90&#x000a0;nmol/L,<xref rid="jah32583-bib-0001" ref-type="ref">1</xref>, <xref rid="jah32583-bib-0002" ref-type="ref">2</xref>, <xref rid="jah32583-bib-0003" ref-type="ref">3</xref>, <xref rid="jah32583-bib-0004" ref-type="ref">4</xref> but substantial uncertainty persists about the causal relevance of low vitamin D concentrations for CVD.<xref rid="jah32583-bib-0005" ref-type="ref">5</xref>, <xref rid="jah32583-bib-0006" ref-type="ref">6</xref> It is possible that the inverse associations of plasma 25(OH)D concentrations with CVD may be caused by confounding by other aspects of lifestyle, and any such effects cannot be entirely excluded in observational studies. Randomized trials are needed to establish causality, but older trials were neither designed to specifically evaluate CVD outcomes, nor used sufficient doses of vitamin D to achieve plasma 25(OH)D concentrations associated with the lowest risks of CVD demonstrated in these observational studies.<xref rid="jah32583-bib-0006" ref-type="ref">6</xref>
</p><p>The mechanisms underlying the associations of vitamin D with CVD are not fully understood,<xref rid="jah32583-bib-0007" ref-type="ref">7</xref> but previous studies have reported inverse associations of plasma 25(OH)D concentrations with hypertension<xref rid="jah32583-bib-0008" ref-type="ref">8</xref> and arterial stiffness.<xref rid="jah32583-bib-0009" ref-type="ref">9</xref> Mendelian randomization studies have reported lower levels of systolic blood pressure among those with genetically lower plasma 25(OH)D concentrations, but the effect sizes of genetically determined differences were very small.<xref rid="jah32583-bib-0010" ref-type="ref">10</xref> Randomized trials of vitamin D and meta&#x02010;analyses of trials have shown no significant effect on blood pressure<xref rid="jah32583-bib-0011" ref-type="ref">11</xref> or arterial stiffness.<xref rid="jah32583-bib-0012" ref-type="ref">12</xref>, <xref rid="jah32583-bib-0013" ref-type="ref">13</xref> It is unclear whether the null results reflect small sample sizes, insufficient dosing of vitamin D, or the relatively short duration of treatment in such trials. Furthermore, low plasma 25(OH)D concentrations have also been associated with heart failure, and may be predictive of poorer outcomes in patients with heart failure,<xref rid="jah32583-bib-0014" ref-type="ref">14</xref>, <xref rid="jah32583-bib-0015" ref-type="ref">15</xref>, <xref rid="jah32583-bib-0016" ref-type="ref">16</xref> but whether supplementation with vitamin D improves cardiac function remains unclear.</p><p>The BEST&#x02010;D (Biochemical Efficacy and Safety Trial of vitamin D) trial evaluated the safety and efficacy of daily supplementation with high&#x02010;dose vitamin D (4000&#x000a0;IU or 2000&#x000a0;IU daily) or placebo for 1&#x000a0;year among older people living in Oxfordshire, United Kingdom, as a pilot study for a large trial of vitamin D for prevention of CVD, fracture, and cancer.<xref rid="jah32583-bib-0017" ref-type="ref">17</xref>, <xref rid="jah32583-bib-0018" ref-type="ref">18</xref> The results of the primary outcomes of the BEST&#x02010;D trial of the effects of supplementation with vitamin D versus placebo on plasma concentrations of 25(OH)D and other plasma markers of vitamin D status have been previously published.<xref rid="jah32583-bib-0018" ref-type="ref">18</xref> The aim of the present report was to describe the effects of supplementation with vitamin D versus placebo on prespecified secondary outcomes of blood pressure, heart rate, and arterial stiffness after 6 and 12&#x000a0;months of treatment; on plasma concentrations of N&#x02010;terminal prohormone of brain natriuretic peptide (NT&#x02010;proBNP) at 12&#x000a0;months; and on echocardiographic measures recorded at 12&#x000a0;months in a randomly selected subset of 177 participants.</p></sec><sec id="jah32583-sec-0010"><title>Methods</title><sec id="jah32583-sec-0011"><title>Study Design and Recruitment</title><p>The study design and the results of the effects of supplementation with vitamin D on plasma concentrations of 25(OH)D and related biochemical markers and other measures in the BEST&#x02010;D trial have been previously reported.<xref rid="jah32583-bib-0017" ref-type="ref">17</xref>, <xref rid="jah32583-bib-0018" ref-type="ref">18</xref> Briefly, participants aged 65&#x000a0;years or older living in the community were recruited by an invitation letter from a single general practice in Banbury, Oxfordshire, United Kingdom, and had to be ambulatory, living in the community, and not taking more than 400&#x000a0;IU (10&#x000a0;&#x003bc;g) vitamin D daily (Figure&#x000a0;<xref rid="jah32583-fig-0001" ref-type="fig">1</xref>). Trained research nurses visited the study participants in their homes at baseline, 6, and 12&#x000a0;months. Information was recorded directly into bespoke electronic case report forms and included medical history, presence of vascular risk factors, and medication use. Blood samples were collected and physical measurements recorded as previously described.<xref rid="jah32583-bib-0017" ref-type="ref">17</xref>, <xref rid="jah32583-bib-0018" ref-type="ref">18</xref> Study visits were scheduled at the same time of the day to minimize any effects of diurnal variation and participants were advised to avoid alcohol, tea, and coffee before each visit. At the 6&#x02010; and 12&#x02010;month visits, compliance with study medications, serious adverse events, and nonserious adverse events leading to discontinuation of study treatment were recorded. During the baseline visit, telephone randomization allocated participants to study treatment (vitamin D 4000&#x000a0;IU or 2000&#x000a0;IU or placebo daily) in a double&#x02010;blind manner. The minimization algorithm included age, body mass index, smoking history, ethnicity, and history of fracture as variables. Vitamin D3 and the matching placebo soft&#x02010;gel capsules were provided by Tischcon Corporation (Westbury, NY, USA) and packaged in child&#x02010;proof containers. All trial investigators, trial staff, and participants were blinded to treatment allocation until the data analysis plan was finalized and the database locked for analysis after trial completion. All participants provided written informed consent to a protocol that was approved by the Multicentre Research Ethics Service Committee (Oxford B), United Kingdom, and complied with the Declaration of Helsinki.</p><fig fig-type="Figure" xml:lang="en" id="jah32583-fig-0001" orientation="portrait" position="float"><label>Figure 1</label><caption><p>
<styled-content style="fixed-case">CONSORT</styled-content> flow diagram for <styled-content style="fixed-case">BEST</styled-content>&#x02010;D trial. BEST&#x02010;D indicates Biochemical Efficacy and Safety Trial of vitamin D; CONSORT, Consolidated Standards of Reporting Trials.</p></caption><graphic id="nlm-graphic-1" xlink:href="JAH3-6-e005707-g001"/></fig></sec><sec id="jah32583-sec-0012"><title>Blood Sample Collection and Biochemical Measurements</title><p>Blood samples were collected at each visit into vacutainers containing either lithium heparin or EDTA, processed within 4&#x000a0;hours, and stored at &#x02212;80&#x000b0;C for further analyses. Plasma concentrations of 25(OH)D were measured using an Access 2 immunoassay analyzer (Beckman Coulter Ltd, High Wycombe, United Kingdom). Plasma concentrations of NT&#x02010;proBNP were measured using an immunoassay with electro&#x02010;chemiluminescent labels (human NT&#x02010;proBNP standard kit, Meso Scale Diagnostics, Rockville, MD, USA) and reading plates on a Sector Imager 6000. Quality control material was run in duplicate with a between&#x02010;run precision of 18% for NT&#x02010;proBNP at 180.5&#x000a0;pg/mL.</p></sec><sec id="jah32583-sec-0013"><title>Blood Pressure and Arterial Stiffness</title><p>Blood pressure and arterial stiffness were measured at each visit after 10&#x000a0;minutes of rest in the seated position. First, a finger probe (Pulsetrace PCA 2) was placed on the right forefinger to record the digital volume pulse trace using photoplethysmography over 30 to 60&#x000a0;s.<xref rid="jah32583-bib-0019" ref-type="ref">19</xref> This was followed by blood pressure and brachial artery arterial stiffness measurements made over 2&#x000a0;minutes using a TensioClinicTM<sup>&#x000ae;</sup> Arteriograph.<xref rid="jah32583-bib-0020" ref-type="ref">20</xref> The systolic and diastolic blood pressure, heart rate, aortic pulse wave velocity, and augmentation index were recorded. The Arteriograph recorded the pressure waveforms at the brachial artery using an oscillometric method after occluding blood flow locally by raising the brachial cuff pressure to 35&#x000a0;mm&#x000a0;Hg above the systolic pressure. The upper edge of the cuff detected the pressure changes over 8&#x000a0;s and calculated the pulse wave velocity (pulse wave velocity=D/[RT/2], where the jugulo&#x02010;symphyseal distance [D] was the approximate length of the descending aorta, divided by the time interval [RT] between the peaks of the forward and reflected waves). Augmentation index reflected the augmented pressure in the central aorta caused by the reflected wave form, expressed as a percentage of central pulse pressure (Augmentation index=100 [P2&#x02013;P1]/PP), where P1 was the amplitude of the forward wave, P2 was the amplitude of the reflected wave, and PP was the pulse pressure. The stiffness index and reflective index were additional measures of peripheral arterial function derived from the Pulsetrace device. The stiffness index was calculated as participant's height/PPT, where PPT was the time between the peaks of the forward and reflected waves measured using the Pulsetrace device, and the reflective index was calculated as the height of the forward wave divided by the height of the reflected wave.</p></sec><sec id="jah32583-sec-0014"><title>Echocardiographic Measures</title><p>From among those randomized and willing to have an echocardiogram, 177 people were randomly selected for echocardiography (ensuring participants were also proportionally selected by month of recruitment). Echocardiographic measurements were recorded at a single center by a cardiologist or trained echocardiography sonographer within 2&#x000a0;weeks of the scheduled final visit. Examinations were conducted using a Philips CX50 ultrasound system. After removing clothing above the waist, participants were asked to lie in the left lateral position with a 30&#x000b0; to 45&#x000b0; elevation of the headrest. Standard image acquisition parasternal (long and short axes) and apical (2&#x02010; and 4&#x02010;chamber) views were obtained. For analyses, 3 consecutive cardiac cycle loops were recorded at end&#x02010;expiration. Ejection fraction (measured by Biplane Simpson's or M&#x02010;mode), fractional shortening, (M&#x02010;mode), and chamber dimensions (2&#x02010;dimensional imaging) were measured. Images were processed using TomTec Imaging Systems software for the outcome measures of left ventricular (LV) systolic function (ejection fraction, fractional shortening, and global longitudinal strain) and diastolic function (E/E<sup>I</sup>, LV internal dimension, LV end&#x02010;diastolic volume, and left atrial [LA] dimension and LA volume). All dimensions and volumes were corrected for body surface area recorded at randomization. Global longitudinal strain estimates were adjusted for heart rate and systolic blood pressure recorded at the time of the examination.</p></sec><sec id="jah32583-sec-0015"><title>Statistical Analyses</title><p>The prespecified co&#x02010;primary outcomes were mean plasma concentration of 25(OH)D at 12&#x000a0;months and the percentage of participants with 12&#x02010;month plasma 25(OH)D concentration &#x0003e;90&#x000a0;nmol/L.<xref rid="jah32583-bib-0017" ref-type="ref">17</xref> Prespecified secondary outcomes included 6&#x02010; and 12&#x02010;month measures of blood pressure, heart rate, and arterial stiffness, and 12&#x02010;month concentration of NT&#x02010;proBNP. Values for NT&#x02010;proBNP were log&#x02010;transformed for all analyses. Participants randomly selected for echocardiography at 12&#x000a0;months had 3 measures of systolic function (ejection fraction, fractional shortening, and global longitudinal strain) and 5 measures of diastolic function (E/E<sup>I</sup>, LV internal dimension, LV end&#x02010;diastolic volume, LA dimension, and LA volume) recorded. It was prespecified that secondary outcomes would be compared between those allocated vitamin D 4000&#x000a0;IU/d and those allocated placebo, between those allocated 2000&#x000a0;IU/d and those allocated placebo, between the 2 active vitamin D doses, and between those allocated either dose of vitamin D versus placebo.<xref rid="jah32583-bib-0017" ref-type="ref">17</xref> The primary method of analysis was an analysis of covariance adjusted for the participant's baseline value (which provides a superior test to a comparison of mean follow&#x02010;up levels or a comparison of mean changes from baseline).<xref rid="jah32583-bib-0021" ref-type="ref">21</xref> Since echocardiographic measures were only recorded at the final visit, comparisons between allocated treatment groups were conducted using analysis of variance with missing data imputed using multiple imputation within allocated groups using Rubin's rules.<xref rid="jah32583-bib-0022" ref-type="ref">22</xref> Analyses were conducted according to the intention&#x02010;to&#x02010;treat principle and all <italic>P</italic> values were 2&#x02010;sided and considered statistically significant at the 5% level (but allowance for multiple testing was made in the interpretation of results). Analyses were conducted independently of the sources of support using SAS version 9.3 and R version 2.11.1.</p></sec></sec><sec id="jah32583-sec-0016"><title>Results</title><sec id="jah32583-sec-0017"><title>Baseline Characteristics</title><p>From September 24, 2012, 305 participants were randomly allocated over a 6&#x02010;month period to take either 4000&#x000a0;IU D (n=102) or 2000&#x000a0;IU D (n=102), or placebo (n=101) daily for 12&#x000a0;months (Figure&#x000a0;<xref rid="jah32583-fig-0001" ref-type="fig">1</xref>). Baseline characteristics by allocated treatment are shown in Table&#x000a0;<xref rid="jah32583-tbl-0001" ref-type="table-wrap">1</xref>. Arteriograph measures were missing for 16% of participants at baseline and 6&#x000a0;months, and 14% of participants at 12&#x000a0;months. Pulse trace measures were missing for 13% of participants at baseline, 16% at 6&#x000a0;months, and 22% at 12&#x000a0;months. Systolic blood pressure at randomization was strongly correlated with aortic augmentation index (<italic>r</italic>=0.41), but more weakly correlated with pulse wave velocity (<italic>r</italic>=0.24), stiffness index (<italic>r</italic>=0.19), and reflection index (<italic>r</italic>=0.17) (Table&#x000a0;<xref rid="jah32583-tbl-0002" ref-type="table-wrap">2</xref>). There was no correlation of either the stiffness or the reflection index measured by the PulseTrace with the pulse wave velocity measured by the Arteriograph (<italic>r</italic>=0.01 and &#x02212;0.08, respectively). None of these baseline vascular measures correlated even moderately with plasma concentrations of 25(OH)D.</p><table-wrap id="jah32583-tbl-0001" xml:lang="en" orientation="portrait" position="float"><label>Table 1</label><caption><p>Participant Characteristics by Allocated Treatment</p></caption><table frame="hsides" rules="groups"><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><thead valign="top"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="top" rowspan="1" colspan="1"/><th align="left" valign="top" rowspan="1" colspan="1">4000&#x000a0;IU/d (n=102)</th><th align="left" valign="top" rowspan="1" colspan="1">2000&#x000a0;IU/d (n=102)</th><th align="left" valign="top" rowspan="1" colspan="1">Placebo (n=101)</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Age, y</td><td align="left" rowspan="1" colspan="1">71 (6)</td><td align="left" rowspan="1" colspan="1">72 (6)</td><td align="left" rowspan="1" colspan="1">72 (6)</td></tr><tr><td align="left" rowspan="1" colspan="1">Male</td><td align="left" rowspan="1" colspan="1">51%</td><td align="left" rowspan="1" colspan="1">50%</td><td align="left" rowspan="1" colspan="1">51%</td></tr><tr><td align="left" rowspan="1" colspan="1">Current smoker</td><td align="left" rowspan="1" colspan="1">7%</td><td align="left" rowspan="1" colspan="1">7%</td><td align="left" rowspan="1" colspan="1">7%</td></tr><tr><td align="left" colspan="4" rowspan="1">Prior disease</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Heart disease<xref ref-type="fn" rid="jah32583-note-0002">a</xref>
</td><td align="left" rowspan="1" colspan="1">20%</td><td align="left" rowspan="1" colspan="1">11%</td><td align="left" rowspan="1" colspan="1">11%</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Stroke/TIA</td><td align="left" rowspan="1" colspan="1">5%</td><td align="left" rowspan="1" colspan="1">8%</td><td align="left" rowspan="1" colspan="1">6%</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Hypertension</td><td align="left" rowspan="1" colspan="1">39%</td><td align="left" rowspan="1" colspan="1">43%</td><td align="left" rowspan="1" colspan="1">35%</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Diabetes mellitus</td><td align="left" rowspan="1" colspan="1">9%</td><td align="left" rowspan="1" colspan="1">9%</td><td align="left" rowspan="1" colspan="1">9%</td></tr><tr><td align="left" colspan="4" rowspan="1">Medication</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Antihypertensives</td><td align="left" rowspan="1" colspan="1">49%</td><td align="left" rowspan="1" colspan="1">51%</td><td align="left" rowspan="1" colspan="1">46%</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Statin</td><td align="left" rowspan="1" colspan="1">31%</td><td align="left" rowspan="1" colspan="1">28%</td><td align="left" rowspan="1" colspan="1">23%</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Antithrombotic</td><td align="left" rowspan="1" colspan="1">20%</td><td align="left" rowspan="1" colspan="1">23%</td><td align="left" rowspan="1" colspan="1">18%</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Vitamin D (&#x02264;400&#x000a0;IU/d)</td><td align="left" rowspan="1" colspan="1">12%</td><td align="left" rowspan="1" colspan="1">10%</td><td align="left" rowspan="1" colspan="1">13%</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Calcium</td><td align="left" rowspan="1" colspan="1">4%</td><td align="left" rowspan="1" colspan="1">1%</td><td align="left" rowspan="1" colspan="1">4%</td></tr><tr><td align="left" colspan="4" rowspan="1">Physical measurements</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Height, cm</td><td align="left" rowspan="1" colspan="1">168 (10)</td><td align="left" rowspan="1" colspan="1">168 (10)</td><td align="left" rowspan="1" colspan="1">167 (10)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Weight, kg</td><td align="left" rowspan="1" colspan="1">77 (17)</td><td align="left" rowspan="1" colspan="1">78 (15)</td><td align="left" rowspan="1" colspan="1">79 (15)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Body mass index, kg/m<sup>2</sup>
</td><td align="left" rowspan="1" colspan="1">27 (5)</td><td align="left" rowspan="1" colspan="1">27 (4)</td><td align="left" rowspan="1" colspan="1">28 (5)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Body surface area, m<sup>2</sup>
</td><td align="left" rowspan="1" colspan="1">1.88 (0.25)</td><td align="left" rowspan="1" colspan="1">1.90 (0.23)</td><td align="left" rowspan="1" colspan="1">1.91 (0.22)</td></tr><tr><td align="left" colspan="4" rowspan="1">Arteriograph measurements</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Systolic blood pressure, mm&#x000a0;Hg</td><td align="left" rowspan="1" colspan="1">132.7 (21.1)</td><td align="left" rowspan="1" colspan="1">131.8 (17.1)</td><td align="left" rowspan="1" colspan="1">129.5 (18.8)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Diastolic blood pressure, mm&#x000a0;Hg</td><td align="left" rowspan="1" colspan="1">78.0 (11.3)</td><td align="left" rowspan="1" colspan="1">76.6 (10.3)</td><td align="left" rowspan="1" colspan="1">76.6 (12.1)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Heart rate, beats/min</td><td align="left" rowspan="1" colspan="1">66.2 (10.5)</td><td align="left" rowspan="1" colspan="1">66.1 (12.1)</td><td align="left" rowspan="1" colspan="1">64.9 (8.8)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Pulse wave velocity, m/s</td><td align="left" rowspan="1" colspan="1">10.0 (1.9)</td><td align="left" rowspan="1" colspan="1">9.6 (1.6)</td><td align="left" rowspan="1" colspan="1">9.7 (1.8)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Aortic augmentation index, %</td><td align="left" rowspan="1" colspan="1">37.7 (16.0)</td><td align="left" rowspan="1" colspan="1">36.8 (14.4)</td><td align="left" rowspan="1" colspan="1">36.0 (15.5)</td></tr><tr><td align="left" colspan="4" rowspan="1">Pulse trace measurements</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Stiffness index, m/s</td><td align="left" rowspan="1" colspan="1">9.2 (2.3)</td><td align="left" rowspan="1" colspan="1">9.1 (2.4)</td><td align="left" rowspan="1" colspan="1">9.5 (2.8)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Reflection index, m/s</td><td align="left" rowspan="1" colspan="1">64.3 (14.0)</td><td align="left" rowspan="1" colspan="1">63.1 (15.4)</td><td align="left" rowspan="1" colspan="1">66.9 (12.5)</td></tr></tbody></table><table-wrap-foot><fn id="jah32583-note-0001"><p>Mean (SD) or % shown. TIA indicates transient ischemic attack.</p></fn><fn id="jah32583-note-0002"><label>a</label><p>Defined as heart attack, angina, or heart failure.</p></fn></table-wrap-foot><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd</copyright-holder></permissions></table-wrap><table-wrap id="jah32583-tbl-0002" xml:lang="en" orientation="portrait" position="float"><label>Table 2</label><caption><p>Correlations Between Particular Baseline Measurements</p></caption><table frame="hsides" rules="groups"><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><thead valign="top"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="top" rowspan="1" colspan="1"/><th align="left" valign="top" rowspan="1" colspan="1">SBP</th><th align="left" valign="top" rowspan="1" colspan="1">DBP</th><th align="left" valign="top" rowspan="1" colspan="1">HR</th><th align="left" valign="top" rowspan="1" colspan="1">PWV</th><th align="left" valign="top" rowspan="1" colspan="1">AAI</th><th align="left" valign="top" rowspan="1" colspan="1">SI</th><th align="left" valign="top" rowspan="1" colspan="1">RI</th><th align="left" valign="top" rowspan="1" colspan="1">25(OH)D</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Systolic blood pressure</td><td align="left" rowspan="1" colspan="1">1.00</td><td align="left" rowspan="1" colspan="1">0.76</td><td align="left" rowspan="1" colspan="1">&#x02212;0.01</td><td align="left" rowspan="1" colspan="1">0.24</td><td align="left" rowspan="1" colspan="1">0.41</td><td align="left" rowspan="1" colspan="1">0.19</td><td align="left" rowspan="1" colspan="1">0.17</td><td align="left" rowspan="1" colspan="1">&#x02212;0.03</td></tr><tr><td align="left" rowspan="1" colspan="1">Diastolic blood pressure</td><td align="left" rowspan="1" colspan="1">&#x000b7;&#x000b7;&#x000b7;</td><td align="left" rowspan="1" colspan="1">1.00</td><td align="left" rowspan="1" colspan="1">0.00</td><td align="left" rowspan="1" colspan="1">0.21</td><td align="left" rowspan="1" colspan="1">0.30</td><td align="left" rowspan="1" colspan="1">0.30</td><td align="left" rowspan="1" colspan="1">0.27</td><td align="left" rowspan="1" colspan="1">0.00</td></tr><tr><td align="left" rowspan="1" colspan="1">Heart rate</td><td align="left" rowspan="1" colspan="1">&#x000b7;&#x000b7;&#x000b7;</td><td align="left" rowspan="1" colspan="1">&#x000b7;&#x000b7;&#x000b7;</td><td align="left" rowspan="1" colspan="1">1.00</td><td align="left" rowspan="1" colspan="1">0.13</td><td align="left" rowspan="1" colspan="1">&#x02212;0.46</td><td align="left" rowspan="1" colspan="1">0.08</td><td align="left" rowspan="1" colspan="1">&#x02212;0.32</td><td align="left" rowspan="1" colspan="1">0.01</td></tr><tr><td align="left" rowspan="1" colspan="1">Pulse wave velocity</td><td align="left" rowspan="1" colspan="1">&#x000b7;&#x000b7;&#x000b7;</td><td align="left" rowspan="1" colspan="1">&#x000b7;&#x000b7;&#x000b7;</td><td align="left" rowspan="1" colspan="1">&#x000b7;&#x000b7;&#x000b7;</td><td align="left" rowspan="1" colspan="1">1.00</td><td align="left" rowspan="1" colspan="1">0.30</td><td align="left" rowspan="1" colspan="1">0.01</td><td align="left" rowspan="1" colspan="1">&#x02212;0.08</td><td align="left" rowspan="1" colspan="1">&#x02212;0.07</td></tr><tr><td align="left" rowspan="1" colspan="1">Aortic augmentation index</td><td align="left" rowspan="1" colspan="1">&#x000b7;&#x000b7;&#x000b7;</td><td align="left" rowspan="1" colspan="1">&#x000b7;&#x000b7;&#x000b7;</td><td align="left" rowspan="1" colspan="1">&#x000b7;&#x000b7;&#x000b7;</td><td align="left" rowspan="1" colspan="1">&#x000b7;&#x000b7;&#x000b7;</td><td align="left" rowspan="1" colspan="1">1.00</td><td align="left" rowspan="1" colspan="1">&#x02212;0.13</td><td align="left" rowspan="1" colspan="1">0.08</td><td align="left" rowspan="1" colspan="1">0.00</td></tr><tr><td align="left" rowspan="1" colspan="1">Stiffness index</td><td align="left" rowspan="1" colspan="1">&#x000b7;&#x000b7;&#x000b7;</td><td align="left" rowspan="1" colspan="1">&#x000b7;&#x000b7;&#x000b7;</td><td align="left" rowspan="1" colspan="1">&#x000b7;&#x000b7;&#x000b7;</td><td align="left" rowspan="1" colspan="1">&#x000b7;&#x000b7;&#x000b7;</td><td align="left" rowspan="1" colspan="1">&#x000b7;&#x000b7;&#x000b7;</td><td align="left" rowspan="1" colspan="1">1.00</td><td align="left" rowspan="1" colspan="1">0.67</td><td align="left" rowspan="1" colspan="1">0.01</td></tr><tr><td align="left" rowspan="1" colspan="1">Reflection index</td><td align="left" rowspan="1" colspan="1">&#x000b7;&#x000b7;&#x000b7;</td><td align="left" rowspan="1" colspan="1">&#x000b7;&#x000b7;&#x000b7;</td><td align="left" rowspan="1" colspan="1">&#x000b7;&#x000b7;&#x000b7;</td><td align="left" rowspan="1" colspan="1">&#x000b7;&#x000b7;&#x000b7;</td><td align="left" rowspan="1" colspan="1">&#x000b7;&#x000b7;&#x000b7;</td><td align="left" rowspan="1" colspan="1">&#x000b7;&#x000b7;&#x000b7;</td><td align="left" rowspan="1" colspan="1">1.00</td><td align="left" rowspan="1" colspan="1">0.03</td></tr><tr><td align="left" rowspan="1" colspan="1">25(OH)D</td><td align="left" rowspan="1" colspan="1">&#x000b7;&#x000b7;&#x000b7;</td><td align="left" rowspan="1" colspan="1">&#x000b7;&#x000b7;&#x000b7;</td><td align="left" rowspan="1" colspan="1">&#x000b7;&#x000b7;&#x000b7;</td><td align="left" rowspan="1" colspan="1">&#x000b7;&#x000b7;&#x000b7;</td><td align="left" rowspan="1" colspan="1">&#x000b7;&#x000b7;&#x000b7;</td><td align="left" rowspan="1" colspan="1">&#x000b7;&#x000b7;&#x000b7;</td><td align="left" rowspan="1" colspan="1">&#x000b7;&#x000b7;&#x000b7;</td><td align="left" rowspan="1" colspan="1">1.00</td></tr></tbody></table><table-wrap-foot><fn id="jah32583-note-0003"><p>AAI indicates aortic augmentation index; DBP, diastolic blood pressure; HR, heart rate; PWV, pulse wave velocity; RI, reflection index; SBP, systolic blood pressure; SI, stiffness index.</p></fn></table-wrap-foot><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd</copyright-holder></permissions></table-wrap><p>The self&#x02010;correlation of values recorded within individuals at 0 and 12&#x000a0;months in the placebo&#x02010;allocated group was 0.74 for systolic blood pressure, 0.69 for diastolic blood pressure, 0.68 for heart rate, 0.72 for pulse wave velocity, and 0.65 for augmentation index, but only 0.50 for stiffness index and 0.45 for reflection index. By contrast, the self&#x02010;correlation for plasma 25(OH)D concentrations over 12&#x000a0;months in the placebo group was 0.90.</p></sec><sec id="jah32583-sec-0018"><title>Effects on Plasma 25(OH)D Concentrations</title><p>Compliance across the 3 treatment arms was comparable. Among those allocated to 4000&#x000a0;IU, 2000&#x000a0;IU, or placebo, 93%, 93%, and 87%, respectively, reported taking their capsules on all or most days at 6&#x000a0;months, while 90%, 92%, and 85% reported doing so at the 12&#x02010;month visit. Mean (SE) plasma 25(OH)D concentrations were 50 (SE 2) nmol/L at baseline and increased to 137 (2.4), 102 (2.4), and 53 (2.4) nmol/L after 12&#x000a0;months of treatment in those allocated 4000&#x000a0;IU/d, 2000&#x000a0;IU/d of vitamin D, or placebo, respectively (Figure&#x000a0;<xref rid="jah32583-fig-0002" ref-type="fig">2</xref>).</p><fig fig-type="Figure" xml:lang="en" id="jah32583-fig-0002" orientation="portrait" position="float"><label>Figure 2</label><caption><p>Effect of allocation to vitamin D vs placebo on mean plasma 25(<styled-content style="fixed-case">OH</styled-content>)D concentrations. Values shown are unadjusted means (95% confidence intervals).</p></caption><graphic id="nlm-graphic-3" xlink:href="JAH3-6-e005707-g002"/></fig></sec><sec id="jah32583-sec-0019"><title>Effects on Blood Pressure and Arterial Stiffness</title><p>Table&#x000a0;<xref rid="jah32583-tbl-0003" ref-type="table-wrap">3</xref> shows mean (SE) levels of blood pressure and arterial stiffness at 6 and 12&#x000a0;months adjusted for baseline levels. When compared with placebo, neither dose of vitamin D (or both doses combined: data not shown) had any significant effect on systolic or diastolic blood pressure, heart rate, aortic augmentation index, stiffness index, or reflection index at either time point. Allocation to vitamin D 4000&#x000a0;IU/d was associated with marginally higher pulse wave velocity at 12&#x000a0;months compared with placebo (10.1 versus 9.6&#x000a0;m/s, <italic>P</italic>=0.009 before accounting for multiple testing).</p><table-wrap id="jah32583-tbl-0003" xml:lang="en" orientation="portrait" position="float"><label>Table 3</label><caption><p>Effect of Allocation to Vitamin D on Blood Pressure and Arterial Stiffness After 6 and 12&#x000a0;Months of Treatment</p></caption><table frame="hsides" rules="groups"><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><thead valign="top"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="top" rowspan="1" colspan="1"/><th align="left" valign="top" rowspan="1" colspan="1">4000&#x000a0;IU/d (n=102)</th><th align="left" valign="top" rowspan="1" colspan="1">2000&#x000a0;IU/d (n=102)</th><th align="left" valign="top" rowspan="1" colspan="1">Placebo (n=101)</th><th align="left" valign="top" rowspan="1" colspan="1">
<italic>P</italic> Value<xref ref-type="fn" rid="jah32583-note-0005">a</xref>
</th><th align="left" valign="top" rowspan="1" colspan="1">
<italic>P</italic> Value<xref ref-type="fn" rid="jah32583-note-0006">b</xref>
</th><th align="left" valign="top" rowspan="1" colspan="1">
<italic>P</italic> Value<xref ref-type="fn" rid="jah32583-note-0007">c</xref>
</th></tr></thead><tbody><tr><td align="left" colspan="7" rowspan="1">Systolic blood pressure, mm&#x000a0;Hg</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">6&#x000a0;mo</td><td align="left" rowspan="1" colspan="1">129.7 (1.31)</td><td align="left" rowspan="1" colspan="1">129.9 (1.36)</td><td align="left" rowspan="1" colspan="1">127.8 (1.44)</td><td align="left" rowspan="1" colspan="1">0.34</td><td align="left" rowspan="1" colspan="1">0.29</td><td align="left" rowspan="1" colspan="1">0.90</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">12&#x000a0;mo</td><td align="left" rowspan="1" colspan="1">132.5 (1.43)</td><td align="left" rowspan="1" colspan="1">131.8 (1.51)</td><td align="left" rowspan="1" colspan="1">131.8 (1.51)</td><td align="left" rowspan="1" colspan="1">0.71</td><td align="left" rowspan="1" colspan="1">0.98</td><td align="left" rowspan="1" colspan="1">0.73</td></tr><tr><td align="left" colspan="7" rowspan="1">Diastolic blood pressure, mm&#x000a0;Hg</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">6&#x000a0;mo</td><td align="left" rowspan="1" colspan="1">75.9 (0.91)</td><td align="left" rowspan="1" colspan="1">76.5 (0.95)</td><td align="left" rowspan="1" colspan="1">75.5 (1.02)</td><td align="left" rowspan="1" colspan="1">0.81</td><td align="left" rowspan="1" colspan="1">0.49</td><td align="left" rowspan="1" colspan="1">0.63</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">12&#x000a0;mo</td><td align="left" rowspan="1" colspan="1">77.2 (0.89)</td><td align="left" rowspan="1" colspan="1">77.0 (0.94)</td><td align="left" rowspan="1" colspan="1">76.6 (0.96)</td><td align="left" rowspan="1" colspan="1">0.65</td><td align="left" rowspan="1" colspan="1">0.73</td><td align="left" rowspan="1" colspan="1">0.92</td></tr><tr><td align="left" colspan="7" rowspan="1">Heart rate, beats/min</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">6&#x000a0;mo</td><td align="left" rowspan="1" colspan="1">64.9 (0.81)</td><td align="left" rowspan="1" colspan="1">65.3 (0.85)</td><td align="left" rowspan="1" colspan="1">66.7 (0.92)</td><td align="left" rowspan="1" colspan="1">0.14</td><td align="left" rowspan="1" colspan="1">0.27</td><td align="left" rowspan="1" colspan="1">0.71</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">12&#x000a0;mo</td><td align="left" rowspan="1" colspan="1">66.0 (0.84)</td><td align="left" rowspan="1" colspan="1">66.4 (0.87)</td><td align="left" rowspan="1" colspan="1">67.0 (0.87)</td><td align="left" rowspan="1" colspan="1">0.40</td><td align="left" rowspan="1" colspan="1">0.64</td><td align="left" rowspan="1" colspan="1">0.72</td></tr><tr><td align="left" colspan="7" rowspan="1">Pulse wave velocity, m/s</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">6&#x000a0;mo</td><td align="left" rowspan="1" colspan="1">9.8 (0.13)</td><td align="left" rowspan="1" colspan="1">9.9 (0.13)</td><td align="left" rowspan="1" colspan="1">9.9 (0.13)</td><td align="left" rowspan="1" colspan="1">0.46</td><td align="left" rowspan="1" colspan="1">0.89</td><td align="left" rowspan="1" colspan="1">0.55</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">12&#x000a0;mo</td><td align="left" rowspan="1" colspan="1">10.1 (0.13)</td><td align="left" rowspan="1" colspan="1">9.9 (0.14)</td><td align="left" rowspan="1" colspan="1">9.6 (0.14)</td><td align="left" rowspan="1" colspan="1">0.009</td><td align="left" rowspan="1" colspan="1">0.20</td><td align="left" rowspan="1" colspan="1">0.19</td></tr><tr><td align="left" colspan="7" rowspan="1">Aortic augmentation index, %</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">6&#x000a0;mo</td><td align="left" rowspan="1" colspan="1">36.7 (1.34)</td><td align="left" rowspan="1" colspan="1">37.5 (1.38)</td><td align="left" rowspan="1" colspan="1">35.0 (1.33)</td><td align="left" rowspan="1" colspan="1">0.36</td><td align="left" rowspan="1" colspan="1">0.19</td><td align="left" rowspan="1" colspan="1">0.68</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">12&#x000a0;mo</td><td align="left" rowspan="1" colspan="1">37.5 (1.28)</td><td align="left" rowspan="1" colspan="1">36.8 (1.36)</td><td align="left" rowspan="1" colspan="1">37.1 (1.38)</td><td align="left" rowspan="1" colspan="1">0.83</td><td align="left" rowspan="1" colspan="1">0.86</td><td align="left" rowspan="1" colspan="1">0.69</td></tr><tr><td align="left" colspan="7" rowspan="1">Pulse trace stiffness index, m/s</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">6&#x000a0;mo</td><td align="left" rowspan="1" colspan="1">9.6 (0.25)</td><td align="left" rowspan="1" colspan="1">9.6 (0.24)</td><td align="left" rowspan="1" colspan="1">9.5 (0.24)</td><td align="left" rowspan="1" colspan="1">0.70</td><td align="left" rowspan="1" colspan="1">0.85</td><td align="left" rowspan="1" colspan="1">0.83</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">12&#x000a0;mo</td><td align="left" rowspan="1" colspan="1">9.4 (0.28)</td><td align="left" rowspan="1" colspan="1">9.4 (0.27)</td><td align="left" rowspan="1" colspan="1">9.5 (0.36)</td><td align="left" rowspan="1" colspan="1">0.94</td><td align="left" rowspan="1" colspan="1">0.98</td><td align="left" rowspan="1" colspan="1">0.96</td></tr><tr><td align="left" colspan="7" rowspan="1">Pulse trace reflection index, m/s</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">6&#x000a0;mo</td><td align="left" rowspan="1" colspan="1">64.6 (1.40)</td><td align="left" rowspan="1" colspan="1">65.4 (1.31)</td><td align="left" rowspan="1" colspan="1">65.2 (1.34)</td><td align="left" rowspan="1" colspan="1">0.75</td><td align="left" rowspan="1" colspan="1">0.89</td><td align="left" rowspan="1" colspan="1">0.66</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">12&#x000a0;mo</td><td align="left" rowspan="1" colspan="1">66.3 (2.17)</td><td align="left" rowspan="1" colspan="1">68.4 (2.53)</td><td align="left" rowspan="1" colspan="1">66.3 (2.32)</td><td align="left" rowspan="1" colspan="1">0.98</td><td align="left" rowspan="1" colspan="1">0.54</td><td align="left" rowspan="1" colspan="1">0.52</td></tr></tbody></table><table-wrap-foot><fn id="jah32583-note-0004"><p>Values shown are mean (SE) adjusted for the baseline value. Missing data were imputed using multiple imputation.</p></fn><fn id="jah32583-note-0005"><label>a</label><p>
<italic>P</italic> value comparing 4000&#x000a0;IU daily vs placebo.</p></fn><fn id="jah32583-note-0006"><label>b</label><p>
<italic>P</italic> value comparing 2000&#x000a0;IU daily vs placebo.</p></fn><fn id="jah32583-note-0007"><label>c</label><p>
<italic>P</italic> value comparing 4000 vs 2000&#x000a0;IU daily.</p></fn></table-wrap-foot><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd</copyright-holder></permissions></table-wrap></sec><sec id="jah32583-sec-0020"><title>Effects on Echocardiographic Measures of Cardiac Function and on Brain Natriuretic Peptide</title><p>Of the 177 participants selected for echocardiographic measures, 44 (15% among those allocated vitamin D and 14% among those allocated placebo) did not attend the appointment for the following reasons: an inability to schedule a visit within 2&#x000a0;weeks of the final visit (n=39), they had died or moved away (n=3), or missed their appointment (n=2). Among those who did attend, levels of ejection fraction were strongly positively correlated with fractional shortening (<italic>r</italic>=0.72) and inversely correlated with LV internal dimension (<italic>r</italic>=&#x02212;0.32) and LA volume (<italic>r</italic>=&#x02212;0.28) (Table&#x000a0;<xref rid="jah32583-tbl-0004" ref-type="table-wrap">4</xref>). None of the echocardiographic measures were strongly correlated with plasma concentration of 25(OH)D or NT&#x02010;proBNP (Table&#x000a0;<xref rid="jah32583-tbl-0004" ref-type="table-wrap">4</xref>).</p><table-wrap id="jah32583-tbl-0004" xml:lang="en" orientation="portrait" position="float"><label>Table 4</label><caption><p>Correlations Between 12&#x02010;Month Measurements of Echocardiographic Parameters, 25(OH)D Concentration, and Ln NT&#x02010;proBNP Concentration</p></caption><table frame="hsides" rules="groups"><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><thead valign="top"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="top" rowspan="1" colspan="1"/><th align="left" valign="top" rowspan="1" colspan="1">EF</th><th align="left" valign="top" rowspan="1" colspan="1">FS</th><th align="left" valign="top" rowspan="1" colspan="1">GLS</th><th align="left" valign="top" rowspan="1" colspan="1">E/E&#x02032;</th><th align="left" valign="top" rowspan="1" colspan="1">LVID</th><th align="left" valign="top" rowspan="1" colspan="1">LVEDV</th><th align="left" valign="top" rowspan="1" colspan="1">LAD</th><th align="left" valign="top" rowspan="1" colspan="1">LAV</th><th align="left" valign="top" rowspan="1" colspan="1">25(OH)D</th><th align="left" valign="top" rowspan="1" colspan="1">Ln NT&#x02010;proBNP</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Ejection fraction</td><td align="left" rowspan="1" colspan="1">1.00</td><td align="left" rowspan="1" colspan="1">0.72</td><td align="left" rowspan="1" colspan="1">&#x02212;0.18</td><td align="left" rowspan="1" colspan="1">0.07</td><td align="left" rowspan="1" colspan="1">&#x02212;0.32</td><td align="left" rowspan="1" colspan="1">&#x02212;0.29</td><td align="left" rowspan="1" colspan="1">&#x02212;0.16</td><td align="left" rowspan="1" colspan="1">&#x02212;0.28</td><td align="left" rowspan="1" colspan="1">0.04</td><td align="left" rowspan="1" colspan="1">0.02</td></tr><tr><td align="left" rowspan="1" colspan="1">Fractional shortening</td><td align="left" rowspan="1" colspan="1">&#x000b7;&#x000b7;&#x000b7;</td><td align="left" rowspan="1" colspan="1">1.00</td><td align="left" rowspan="1" colspan="1">&#x02212;0.17</td><td align="left" rowspan="1" colspan="1">0.11</td><td align="left" rowspan="1" colspan="1">&#x02212;0.29</td><td align="left" rowspan="1" colspan="1">&#x02212;0.31</td><td align="left" rowspan="1" colspan="1">&#x02212;0.10</td><td align="left" rowspan="1" colspan="1">&#x02212;0.25</td><td align="left" rowspan="1" colspan="1">0.00</td><td align="left" rowspan="1" colspan="1">0.07</td></tr><tr><td align="left" rowspan="1" colspan="1">Global longitudinal strain</td><td align="left" rowspan="1" colspan="1">&#x000b7;&#x000b7;&#x000b7;</td><td align="left" rowspan="1" colspan="1">&#x000b7;&#x000b7;&#x000b7;</td><td align="left" rowspan="1" colspan="1">1.00</td><td align="left" rowspan="1" colspan="1">&#x02212;0.03</td><td align="left" rowspan="1" colspan="1">0.10</td><td align="left" rowspan="1" colspan="1">0.20</td><td align="left" rowspan="1" colspan="1">0.19</td><td align="left" rowspan="1" colspan="1">0.11</td><td align="left" rowspan="1" colspan="1">&#x02212;0.08</td><td align="left" rowspan="1" colspan="1">&#x02212;0.04</td></tr><tr><td align="left" rowspan="1" colspan="1">E/E<sup>I</sup>
</td><td align="left" rowspan="1" colspan="1">&#x000b7;&#x000b7;&#x000b7;</td><td align="left" rowspan="1" colspan="1">&#x000b7;&#x000b7;&#x000b7;</td><td align="left" rowspan="1" colspan="1">&#x000b7;&#x000b7;&#x000b7;</td><td align="left" rowspan="1" colspan="1">1.00</td><td align="left" rowspan="1" colspan="1">&#x02212;0.14</td><td align="left" rowspan="1" colspan="1">&#x02212;0.15</td><td align="left" rowspan="1" colspan="1">&#x02212;0.10</td><td align="left" rowspan="1" colspan="1">&#x02212;0.04</td><td align="left" rowspan="1" colspan="1">&#x02212;0.07</td><td align="left" rowspan="1" colspan="1">0.13</td></tr><tr><td align="left" rowspan="1" colspan="1">LV internal dimension</td><td align="left" rowspan="1" colspan="1">&#x000b7;&#x000b7;&#x000b7;</td><td align="left" rowspan="1" colspan="1">&#x000b7;&#x000b7;&#x000b7;</td><td align="left" rowspan="1" colspan="1">&#x000b7;&#x000b7;&#x000b7;</td><td align="left" rowspan="1" colspan="1">&#x000b7;&#x000b7;&#x000b7;</td><td align="left" rowspan="1" colspan="1">1.00</td><td align="left" rowspan="1" colspan="1">0.76</td><td align="left" rowspan="1" colspan="1">0.32</td><td align="left" rowspan="1" colspan="1">0.48</td><td align="left" rowspan="1" colspan="1">0.00</td><td align="left" rowspan="1" colspan="1">0.04</td></tr><tr><td align="left" rowspan="1" colspan="1">LV end&#x02010;diastolic volume</td><td align="left" rowspan="1" colspan="1">&#x000b7;&#x000b7;&#x000b7;</td><td align="left" rowspan="1" colspan="1">&#x000b7;&#x000b7;&#x000b7;</td><td align="left" rowspan="1" colspan="1">&#x000b7;&#x000b7;&#x000b7;</td><td align="left" rowspan="1" colspan="1">&#x000b7;&#x000b7;&#x000b7;</td><td align="left" rowspan="1" colspan="1">&#x000b7;&#x000b7;&#x000b7;</td><td align="left" rowspan="1" colspan="1">1.00</td><td align="left" rowspan="1" colspan="1">0.46</td><td align="left" rowspan="1" colspan="1">0.49</td><td align="left" rowspan="1" colspan="1">&#x02212;0.02</td><td align="left" rowspan="1" colspan="1">&#x02212;0.02</td></tr><tr><td align="left" rowspan="1" colspan="1">LA dimension</td><td align="left" rowspan="1" colspan="1">&#x000b7;&#x000b7;&#x000b7;</td><td align="left" rowspan="1" colspan="1">&#x000b7;&#x000b7;&#x000b7;</td><td align="left" rowspan="1" colspan="1">&#x000b7;&#x000b7;&#x000b7;</td><td align="left" rowspan="1" colspan="1">&#x000b7;&#x000b7;&#x000b7;</td><td align="left" rowspan="1" colspan="1">&#x000b7;&#x000b7;&#x000b7;</td><td align="left" rowspan="1" colspan="1">&#x000b7;&#x000b7;&#x000b7;</td><td align="left" rowspan="1" colspan="1">1.00</td><td align="left" rowspan="1" colspan="1">0.50</td><td align="left" rowspan="1" colspan="1">&#x02212;0.16</td><td align="left" rowspan="1" colspan="1">0.14</td></tr><tr><td align="left" rowspan="1" colspan="1">LA volume</td><td align="left" rowspan="1" colspan="1">&#x000b7;&#x000b7;&#x000b7;</td><td align="left" rowspan="1" colspan="1">&#x000b7;&#x000b7;&#x000b7;</td><td align="left" rowspan="1" colspan="1">&#x000b7;&#x000b7;&#x000b7;</td><td align="left" rowspan="1" colspan="1">&#x000b7;&#x000b7;&#x000b7;</td><td align="left" rowspan="1" colspan="1">&#x000b7;&#x000b7;&#x000b7;</td><td align="left" rowspan="1" colspan="1">&#x000b7;&#x000b7;&#x000b7;</td><td align="left" rowspan="1" colspan="1">&#x000b7;&#x000b7;&#x000b7;</td><td align="left" rowspan="1" colspan="1">1.00</td><td align="left" rowspan="1" colspan="1">&#x02212;0.20</td><td align="left" rowspan="1" colspan="1">0.12</td></tr><tr><td align="left" rowspan="1" colspan="1">25(OH)D</td><td align="left" rowspan="1" colspan="1">&#x000b7;&#x000b7;&#x000b7;</td><td align="left" rowspan="1" colspan="1">&#x000b7;&#x000b7;&#x000b7;</td><td align="left" rowspan="1" colspan="1">&#x000b7;&#x000b7;&#x000b7;</td><td align="left" rowspan="1" colspan="1">&#x000b7;&#x000b7;&#x000b7;</td><td align="left" rowspan="1" colspan="1">&#x000b7;&#x000b7;&#x000b7;</td><td align="left" rowspan="1" colspan="1">&#x000b7;&#x000b7;&#x000b7;</td><td align="left" rowspan="1" colspan="1">&#x000b7;&#x000b7;&#x000b7;</td><td align="left" rowspan="1" colspan="1">&#x000b7;&#x000b7;&#x000b7;</td><td align="left" rowspan="1" colspan="1">1.00</td><td align="left" rowspan="1" colspan="1">0.04</td></tr><tr><td align="left" rowspan="1" colspan="1">Ln NT&#x02010;proBNP</td><td align="left" rowspan="1" colspan="1">&#x000b7;&#x000b7;&#x000b7;</td><td align="left" rowspan="1" colspan="1">&#x000b7;&#x000b7;&#x000b7;</td><td align="left" rowspan="1" colspan="1">&#x000b7;&#x000b7;&#x000b7;</td><td align="left" rowspan="1" colspan="1">&#x000b7;&#x000b7;&#x000b7;</td><td align="left" rowspan="1" colspan="1">&#x000b7;&#x000b7;&#x000b7;</td><td align="left" rowspan="1" colspan="1">&#x000b7;&#x000b7;&#x000b7;</td><td align="left" rowspan="1" colspan="1">&#x000b7;&#x000b7;&#x000b7;</td><td align="left" rowspan="1" colspan="1">&#x000b7;&#x000b7;&#x000b7;</td><td align="left" rowspan="1" colspan="1">&#x000b7;&#x000b7;&#x000b7;</td><td align="left" rowspan="1" colspan="1">1.00</td></tr></tbody></table><table-wrap-foot><fn id="jah32583-note-0008"><p>E/E<sup>I</sup> indicates ratio of early peak inflow velocity to early diastolic peak lateral mitral annular velocity; EF, ejection fraction; FS, fractional shortening; GLS, global longitudinal strain; LAD, left atrial dimension; LAV, left atrial volume; LVEDV, left ventricular end&#x02010;diastolic volume; LVID, left ventricular internal dimension; NT&#x02010;proBNP, N&#x02010;terminal prohormone of brain natriuretic peptide.</p></fn></table-wrap-foot><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd</copyright-holder></permissions></table-wrap><p>Allocation to either dose of vitamin D compared with placebo had no significant effect on any measure of either systolic or diastolic function at 12&#x000a0;months (Table&#x000a0;<xref rid="jah32583-tbl-0005" ref-type="table-wrap">5</xref>). Likewise, allocation to either dose of vitamin D had no significant effect on plasma concentration of Ln NT&#x02010;ProBNP (6.1 [0.1] versus 6.2 [0.1] Ln pg/mL; <italic>P</italic>=0.11: Table&#x000a0;<xref rid="jah32583-tbl-0005" ref-type="table-wrap">5</xref>). Even in post&#x02010;hoc analyses among the subgroup with an ejection fraction of &#x0003c;50%, there was no suggestion of any beneficial effect of vitamin D supplementation (data not shown).</p><table-wrap id="jah32583-tbl-0005" xml:lang="en" orientation="portrait" position="float"><label>Table 5</label><caption><p>Effect of Allocation to Vitamin D3 (4000&#x000a0;IU or 2000&#x000a0;IU Daily) Versus Placebo on Echocardiographic Measures of Systolic and Diastolic Cardiac Function After 12&#x000a0;Months of Treatment and on Plasma Concentrations of NT&#x02010;proBNP</p></caption><table frame="hsides" rules="groups"><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000" span="1"/><thead valign="top"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="top" rowspan="1" colspan="1"/><th align="left" valign="top" rowspan="1" colspan="1">Either Dose of Vitamin D</th><th align="left" valign="top" rowspan="1" colspan="1">Placebo</th><th align="left" valign="top" rowspan="1" colspan="1">
<italic>P</italic> Value</th></tr></thead><tbody><tr><td align="left" colspan="4" rowspan="1">Systolic function</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Ejection fraction, %</td><td align="left" rowspan="1" colspan="1">60.5 (1.1)</td><td align="left" rowspan="1" colspan="1">60.8 (1.7)</td><td align="left" rowspan="1" colspan="1">0.89</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Fractional shortening, %</td><td align="left" rowspan="1" colspan="1">30.8 (1.1)</td><td align="left" rowspan="1" colspan="1">30.8 (1.5)</td><td align="left" rowspan="1" colspan="1">0.98</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Global longitudinal strain, % <xref ref-type="fn" rid="jah32583-note-0010">a</xref>
</td><td align="left" rowspan="1" colspan="1">&#x02212;19.9 (0.8)</td><td align="left" rowspan="1" colspan="1">&#x02212;19.5 (1.17)</td><td align="left" rowspan="1" colspan="1">0.73</td></tr><tr><td align="left" colspan="4" rowspan="1">Diastolic function</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">E/E<sup>I</sup>
</td><td align="left" rowspan="1" colspan="1">7.2 (0.3)</td><td align="left" rowspan="1" colspan="1">7.8 (0.4)</td><td align="left" rowspan="1" colspan="1">0.23</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">LV internal dimension, cm<xref ref-type="fn" rid="jah32583-note-0011">b</xref>
</td><td align="left" rowspan="1" colspan="1">4.8 (0.1)</td><td align="left" rowspan="1" colspan="1">4.7 (0.1)</td><td align="left" rowspan="1" colspan="1">0.65</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">LV end&#x02010;diastolic volume, mL/m&#x000b2;<xref ref-type="fn" rid="jah32583-note-0011">b</xref>
</td><td align="left" rowspan="1" colspan="1">105.3 (3.4)</td><td align="left" rowspan="1" colspan="1">106.2 (4.7)</td><td align="left" rowspan="1" colspan="1">0.88</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">LA dimension, cm<xref ref-type="fn" rid="jah32583-note-0011">b</xref>
</td><td align="left" rowspan="1" colspan="1">3.8 (0.1)</td><td align="left" rowspan="1" colspan="1">3.9 (0.1)</td><td align="left" rowspan="1" colspan="1">0.28</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">LA volume, mL/m<sup>2</sup>
<xref ref-type="fn" rid="jah32583-note-0011">b</xref>
</td><td align="left" rowspan="1" colspan="1">44.2 (2.0)</td><td align="left" rowspan="1" colspan="1">41.7 (2.9)</td><td align="left" rowspan="1" colspan="1">0.47</td></tr><tr><td align="left" rowspan="1" colspan="1">Ln NT&#x02010;proBNP, ln pg/mL</td><td align="left" rowspan="1" colspan="1">6.1 (0.1)</td><td align="left" rowspan="1" colspan="1">6.2 (0.1)</td><td align="left" rowspan="1" colspan="1">0.11</td></tr></tbody></table><table-wrap-foot><fn id="jah32583-note-0009"><p>Values shown are mean (SE). Missing data were imputed using multiple imputation. Analyses of echocardiography (including missing data imputation) were limited to the subset of 177 participants (117 on either dose of vitamin D and 60 on placebo) who were randomly selected to have an echocardiogram at 12&#x000a0;mo and did not have artificial valves (2 patients) or severe aortic stenosis (1 patient) at the time of examination. E/E<sup>I</sup> indicates ratio of early peak inflow velocity to early diastolic peak lateral mitral annular velocity; LV, left ventricular; NT&#x02010;proBNP, N&#x02010;terminal prohormone of brain natriuretic peptide; SBP, systolic blood pressure.</p></fn><fn id="jah32583-note-0010"><label>a</label><p>Adjusted for heart rate and SBP at the time of examination.</p></fn><fn id="jah32583-note-0011"><label>b</label><p>Adjusted for body surface area at randomization.</p></fn></table-wrap-foot><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd</copyright-holder></permissions></table-wrap></sec><sec id="jah32583-sec-0021"><title>Sensitivity Analyses</title><p>For all outcomes, results of all treatment comparisons were not materially altered when restricted to participants with no missing data (ie, complete case analyses: data not shown).</p></sec></sec><sec id="jah32583-sec-0022"><title>Discussion</title><p>Despite allocation to vitamin D achieving and maintaining plasma 25(OH)D concentrations more than 2&#x02010;fold greater than those allocated to placebo for 1&#x000a0;year, supplementation with high&#x02010;dose vitamin D did not have any significant effect on systolic or diastolic blood pressure or on measures of central or peripheral arterial stiffness. Similarly, vitamin D had no effect on any echocardiographic measures of systolic or diastolic cardiac function or on biochemical markers of cardiac function.</p><p>While these results for the effects of vitamin D on blood pressure and arterial stiffness are consistent with the evidence from previous meta&#x02010;analysis of randomized trials evaluating effects of vitamin D on blood pressure<xref rid="jah32583-bib-0023" ref-type="ref">23</xref> and arterial stiffness,<xref rid="jah32583-bib-0013" ref-type="ref">13</xref> the present trial assessed the effects of both higher doses of vitamin D and longer duration of treatment than most of the previous trials addressing these questions. A meta&#x02010;analysis of previously published trials, including individual participant data from 27 other trials involving 3092 participants, demonstrated no effect of vitamin D supplementation on blood pressure (systolic blood pressure &#x02212;0.5&#x000a0;mm&#x000a0;Hg; 95% confidence interval, &#x02212;1.3 to 0.4; <italic>P</italic>=0.27).<xref rid="jah32583-bib-0023" ref-type="ref">23</xref>
</p><p>Likewise, previous trials assessing the effects of supplementation with vitamin D on cardiac function have reported conflicting results. The PRIMO (Paricalcitol Capsule Benefits in Renal Failure &#x02010; Induced Cardiac Morbidity) trial<xref rid="jah32583-bib-0024" ref-type="ref">24</xref> (n=227) in patients with chronic kidney disease reported that calcitriol treatment for 48&#x000a0;weeks had no beneficial effects on cardiac function. The VINDICATE (Vitamin D Treating Patients with Chronic Heart Failure) trial<xref rid="jah32583-bib-0025" ref-type="ref">25</xref> (n=229), which involved patients with heart failure and a mean ejection fraction of 26%, reported that 4000&#x000a0;IU vitamin D daily for 12&#x000a0;months increased LV ejection fraction by 6% (95% confidence interval, 3.20&#x02013;8.95, <italic>P</italic>&#x0003c;0.0001) and reduced LV end&#x02010;systolic or diastolic volume, although there was no impact on 6&#x02010;minute walking distance, which was the prespecified primary end point. However, the present trial with echocardiographic measures in 177 healthy older participants and mean ejection fraction of 60% demonstrated no beneficial effects of vitamin D on any echocardiographic measures of systolic or diastolic function or on global longitudinal strain, although for this population, the mean LV function was in the normal range.</p><p>While the limitations of the Arteriograph and Pulsetrace devices for assessing arterial stiffness are acknowledged (reflected by the lower self&#x02010;correlations compared with standard blood pressure measures),<xref rid="jah32583-bib-0026" ref-type="ref">26</xref> the absence of effects of high&#x02010;dose vitamin D on blood pressure and arterial stiffness observed in this report does not support supplementation with vitamin D for CVD prevention being mediated through any of these mechanisms. Nevertheless, this study cannot exclude benefits for CVD prevention beyond 1&#x000a0;year of treatment, or those mediated through other mechanisms. The absence of effects of vitamin D on cardiac function, including assessments of strain imaging, may also reflect the relatively healthy participant cohort and their stable cardiac function as the mean blood pressure and LV ejection fraction were within the expected normal range for this age group.</p><p>The mean plasma 25(OH)D concentrations in this population were also similar to those of healthy adults living in the United Kingdom.<xref rid="jah32583-bib-0002" ref-type="ref">2</xref> However, despite the lack of demonstrable effect in this study, the effects of vitamin D supplementation in those with lower mean plasma 25(OH)D concentrations or pre&#x02010;existing heart failure cannot be entirely excluded. Over 95% of the participants reported having European ancestry and, hence, the study was unable to assess any differential effects of vitamin D in other ethnic groups. Published reports of completed large trials assessing the effects of vitamin D on incident cardiovascular events are difficult to interpret given the relatively modest doses of vitamin D (400&#x02013;800&#x000a0;IU daily) assessed.<xref rid="jah32583-bib-0027" ref-type="ref">27</xref>, <xref rid="jah32583-bib-0028" ref-type="ref">28</xref> However, ongoing large trials, involving over 56&#x000a0;000 participants, are currently assessing the effects of much higher doses of vitamin D on CVD and other disease outcomes.<xref rid="jah32583-bib-0029" ref-type="ref">29</xref>, <xref rid="jah32583-bib-0030" ref-type="ref">30</xref>, <xref rid="jah32583-bib-0031" ref-type="ref">31</xref> For example, these trials are testing vitamin D doses of 2000&#x000a0;IU daily (VITAL (Vitamin D and Omega&#x02010;3 Trial): n=25&#x000a0;897), 60&#x000a0;000&#x000a0;IU monthly (D&#x02010;Health (D&#x02010;Health Trial: a randomised trial of vitamin D for prevention of mortality an cancer): n=20&#x000a0;000) and 60&#x000a0;000&#x000a0;IU monthly (TIPS&#x02010;3 (International Polycap Study 3): n=5500). Recently, the ViDA (Vitamin D Assessment Study) trial also reported no beneficial effects of supplementation with vitamin D (administered as 100&#x000a0;000&#x000a0;IU monthly for 3.3&#x000a0;years) on CVD outcome in 5108 participants.<xref rid="jah32583-bib-0032" ref-type="ref">32</xref> Given the lack of any beneficial effects on CVD outcomes in several randomized&#x02010;controlled trials conducted to date, and additional uncertainty about the relevance of vitamin D for incidence of diabetes mellitus,<xref rid="jah32583-bib-0033" ref-type="ref">33</xref>, <xref rid="jah32583-bib-0034" ref-type="ref">34</xref> the results of ongoing and future trials of vitamin D supplementation are required to address the effects of vitamin D on incident CVD outcomes, in addition to effects on fracture and other disease outcomes, before advocating use of vitamin D supplements for prevention of CVD.<xref rid="jah32583-bib-0035" ref-type="ref">35</xref>
</p></sec><sec id="jah32583-sec-0024"><title>Sources of Funding</title><p>This work was supported by the British Heart Foundation, the BHF Centre of Research Excellence and Clinical Trial Service Unit, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom.</p></sec><sec id="jah32583-sec-0025"><title>Disclosures</title><p>None.</p></sec></body><back><ack id="jah32583-sec-0023"><title>Acknowledgments</title><p>We would like to thank Jenny Sayer for administrative support for the trial.</p></ack><ref-list content-type="cited-references" id="jah32583-bibl-0001"><title>References</title><ref id="jah32583-bib-0001"><label>1</label><mixed-citation publication-type="journal" id="jah32583-cit-0001">
<string-name>
<surname>Zittermann</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Iodice</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Pilz</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Grant</surname>
<given-names>WB</given-names>
</string-name>, <string-name>
<surname>Bagnardi</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Gandini</surname>
<given-names>S</given-names>
</string-name>. <article-title>Vitamin D deficiency and mortality risk in the general population: a meta&#x02010;analysis of prospective cohort studies</article-title>. <source>Am J Clin Nutr</source>. <year>2012</year>;<volume>95</volume>:<fpage>91</fpage>&#x02013;<lpage>100</lpage>.<pub-id pub-id-type="pmid">22170374</pub-id></mixed-citation></ref><ref id="jah32583-bib-0002"><label>2</label><mixed-citation publication-type="journal" id="jah32583-cit-0002">
<string-name>
<surname>Tomson</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Emberson</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Hill</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Gordon</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Armitage</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Shipley</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Collins</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Clarke</surname>
<given-names>R</given-names>
</string-name>. <article-title>Vitamin D and risk of death from vascular and non&#x02010;vascular causes in the Whitehall study and meta&#x02010;analyses of 12,000 deaths</article-title>. <source>Eur Heart J</source>. <year>2013</year>;<volume>34</volume>:<fpage>1365</fpage>&#x02013;<lpage>1374</lpage>.<pub-id pub-id-type="pmid">23257953</pub-id></mixed-citation></ref><ref id="jah32583-bib-0003"><label>3</label><mixed-citation publication-type="journal" id="jah32583-cit-0003">
<string-name>
<surname>Schottker</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Jorde</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Peasey</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Thorand</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Jansen</surname>
<given-names>EH</given-names>
</string-name>, <string-name>
<surname>Groot</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Streppel</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Gardiner</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Ord&#x000f3;&#x000f1;ez&#x02010;Mena</surname>
<given-names>JM</given-names>
</string-name>, <string-name>
<surname>Perna</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Wilsgaard</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Rathmann</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Feskens</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Kampman</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Siganos</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Nj&#x000f8;lstad</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Mathiesen</surname>
<given-names>EB</given-names>
</string-name>, <string-name>
<surname>Kub&#x000ed;nov&#x000e1;</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Paj&#x00105;k</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Topor&#x02010;Madry</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Tamosiunas</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Hughes</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Kee</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Bobak</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Trichopoulou</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Boffetta</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Brenner</surname>
<given-names>H</given-names>
</string-name>; <collab collab-type="authors">Consortium on Health and Ageing: Network of Cohorts in Europe and the United States</collab>
. <article-title>Vitamin D and mortality: meta&#x02010;analysis of individual participant data from a large consortium of cohort studies from Europe and the United States</article-title>. <source>BMJ</source>. <year>2014</year>;<volume>348</volume>:<fpage>g3656</fpage>.<pub-id pub-id-type="pmid">24938302</pub-id></mixed-citation></ref><ref id="jah32583-bib-0004"><label>4</label><mixed-citation publication-type="journal" id="jah32583-cit-0004">
<string-name>
<surname>Khaw</surname>
<given-names>KT</given-names>
</string-name>, <string-name>
<surname>Luben</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Wareham</surname>
<given-names>N</given-names>
</string-name>. <article-title>Serum 25&#x02010;hydroxyvitamin D, mortality, and incident cardiovascular disease, respiratory disease, cancers, and fractures: a 13&#x02010;y prospective population study</article-title>. <source>Am J Clin Nutr</source>. <year>2014</year>;<volume>100</volume>:<fpage>1361</fpage>&#x02013;<lpage>1370</lpage>.<pub-id pub-id-type="pmid">25332334</pub-id></mixed-citation></ref><ref id="jah32583-bib-0005"><label>5</label><mixed-citation publication-type="journal" id="jah32583-cit-0005">
<string-name>
<surname>Wang</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Song</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Manson</surname>
<given-names>JE</given-names>
</string-name>, <string-name>
<surname>Pilz</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>M&#x000e4;rz</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Micha&#x000eb;lsson</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Lundqvist</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Jassal</surname>
<given-names>SK</given-names>
</string-name>, <string-name>
<surname>Barrett&#x02010;Connor</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Eaton</surname>
<given-names>CB</given-names>
</string-name>, <string-name>
<surname>May</surname>
<given-names>HT</given-names>
</string-name>, <string-name>
<surname>Anderson</surname>
<given-names>JL</given-names>
</string-name>, <string-name>
<surname>Sesso</surname>
<given-names>HD</given-names>
</string-name>. <article-title>Circulating 25&#x02010;hydroxy&#x02010;vitamin D and risk of cardiovascular disease: a meta&#x02010;analysis of prospective studies</article-title>. <source>Circ Cardiovasc Qual Outcomes</source>. <year>2012</year>;<volume>5</volume>:<fpage>819</fpage>&#x02013;<lpage>829</lpage>.<pub-id pub-id-type="pmid">23149428</pub-id></mixed-citation></ref><ref id="jah32583-bib-0006"><label>6</label><mixed-citation publication-type="journal" id="jah32583-cit-0006">
<string-name>
<surname>Weyland</surname>
<given-names>PG</given-names>
</string-name>, <string-name>
<surname>Grant</surname>
<given-names>WB</given-names>
</string-name>, <string-name>
<surname>Howie&#x02010;Esquivel</surname>
<given-names>J</given-names>
</string-name>. <article-title>Does sufficient evidence exist to support a causal association between vitamin D status and cardiovascular disease risk? An assessment using Hill's criteria for causality</article-title>. <source>Nutrients</source>. <year>2014</year>;<volume>6</volume>:<fpage>3403</fpage>&#x02013;<lpage>3430</lpage>.<pub-id pub-id-type="pmid">25184368</pub-id></mixed-citation></ref><ref id="jah32583-bib-0007"><label>7</label><mixed-citation publication-type="journal" id="jah32583-cit-0007">
<string-name>
<surname>Kunadian</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Ford</surname>
<given-names>GA</given-names>
</string-name>, <string-name>
<surname>Bawamia</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Qiu</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Manson</surname>
<given-names>JE</given-names>
</string-name>. <article-title>Vitamin D deficiency and coronary artery disease: a review of the evidence</article-title>. <source>Am Heart J</source>. <year>2014</year>;<volume>167</volume>:<fpage>283</fpage>&#x02013;<lpage>291</lpage>.<pub-id pub-id-type="pmid">24576510</pub-id></mixed-citation></ref><ref id="jah32583-bib-0008"><label>8</label><mixed-citation publication-type="journal" id="jah32583-cit-0008">
<string-name>
<surname>Pittas</surname>
<given-names>AG</given-names>
</string-name>, <string-name>
<surname>Chung</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Trikalinos</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Mitri</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Brendel</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Patel</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Lichtenstein</surname>
<given-names>AH</given-names>
</string-name>, <string-name>
<surname>Lau</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Balk</surname>
<given-names>EM</given-names>
</string-name>. <article-title>Systematic review: Vitamin D and cardiometabolic outcomes</article-title>. <source>Ann Intern Med</source>. <year>2010</year>;<volume>152</volume>:<fpage>307</fpage>&#x02013;<lpage>314</lpage>.<pub-id pub-id-type="pmid">20194237</pub-id></mixed-citation></ref><ref id="jah32583-bib-0009"><label>9</label><mixed-citation publication-type="journal" id="jah32583-cit-0009">
<string-name>
<surname>Al Mheid</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Patel</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Murrow</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Morris</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Rahman</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Fike</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Kavtaradze</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Uphoff</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Hooper</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Tangpricha</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Alexander</surname>
<given-names>RW</given-names>
</string-name>, <string-name>
<surname>Brigham</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Quyyumi</surname>
<given-names>AA</given-names>
</string-name>. <article-title>Vitamin D status is associated with arterial stiffness and vascular dysfunction in healthy humans</article-title>. <source>J Am Coll Cardiol</source>. <year>2011</year>;<volume>58</volume>:<fpage>186</fpage>&#x02013;<lpage>192</lpage>.<pub-id pub-id-type="pmid">21718915</pub-id></mixed-citation></ref><ref id="jah32583-bib-0010"><label>10</label><mixed-citation publication-type="journal" id="jah32583-cit-0010">
<string-name>
<surname>Vimaleswaran</surname>
<given-names>KS</given-names>
</string-name>, <string-name>
<surname>Cavadino</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Berry</surname>
<given-names>DJ</given-names>
</string-name>; <collab collab-type="authors">LifeLines Cohort Study investigators</collab>
, <string-name>
<surname>Jorde</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Dieffenbach</surname>
<given-names>AK</given-names>
</string-name>, <string-name>
<surname>Lu</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Alves</surname>
<given-names>AC</given-names>
</string-name>, <string-name>
<surname>Heerspink</surname>
<given-names>HJ</given-names>
</string-name>, <string-name>
<surname>Tikkanen</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Eriksson</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Wong</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Mangino</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Jablonski</surname>
<given-names>KA</given-names>
</string-name>, <string-name>
<surname>Nolte</surname>
<given-names>IM</given-names>
</string-name>, <string-name>
<surname>Houston</surname>
<given-names>DK</given-names>
</string-name>, <string-name>
<surname>Ahluwalia</surname>
<given-names>TS</given-names>
</string-name>, <string-name>
<surname>van der Most</surname>
<given-names>PJ</given-names>
</string-name>, <string-name>
<surname>Pasko</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Zgaga</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Thiering</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Vitart</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Fraser</surname>
<given-names>RM</given-names>
</string-name>, <string-name>
<surname>Huffman</surname>
<given-names>JE</given-names>
</string-name>, <string-name>
<surname>de Boer</surname>
<given-names>RA</given-names>
</string-name>, <string-name>
<surname>Sch&#x000f6;ttker</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Saum</surname>
<given-names>KU</given-names>
</string-name>, <string-name>
<surname>McCarthy</surname>
<given-names>MI</given-names>
</string-name>, <string-name>
<surname>Dupuis</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Herzig</surname>
<given-names>KH</given-names>
</string-name>, <string-name>
<surname>Sebert</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Pouta</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Laitinen</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Kleber</surname>
<given-names>ME</given-names>
</string-name>, <string-name>
<surname>Navis</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Lorentzon</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Jameson</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Arden</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Cooper</surname>
<given-names>JA</given-names>
</string-name>, <string-name>
<surname>Acharya</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Hardy</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Raitakari</surname>
<given-names>O</given-names>
</string-name>, <string-name>
<surname>Ripatti</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Billings</surname>
<given-names>LK</given-names>
</string-name>, <string-name>
<surname>Lahti</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Osmond</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Penninx</surname>
<given-names>BW</given-names>
</string-name>, <string-name>
<surname>Rejnmark</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Lohman</surname>
<given-names>KK</given-names>
</string-name>, <string-name>
<surname>Paternoster</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Stolk</surname>
<given-names>RP</given-names>
</string-name>, <string-name>
<surname>Hernandez</surname>
<given-names>DG</given-names>
</string-name>, <string-name>
<surname>Byberg</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Hagstr&#x000f6;m</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Melhus</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Ingelsson</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Mellstr&#x000f6;m</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Ljunggren</surname>
<given-names>O</given-names>
</string-name>, <string-name>
<surname>Tzoulaki</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>McLachlan</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Theodoratou</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Tiesler</surname>
<given-names>CM</given-names>
</string-name>, <string-name>
<surname>Jula</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Navarro</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Wright</surname>
<given-names>AF</given-names>
</string-name>, <string-name>
<surname>Polasek</surname>
<given-names>O</given-names>
</string-name>; <collab collab-type="authors">International Consortium for Blood Pressure (ICBP); Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) consortium; Global Blood Pressure Genetics (Global BPGen) consortium; Caroline Hayward</collab>
, <string-name>
<surname>Wilson</surname>
<given-names>JF</given-names>
</string-name>, <string-name>
<surname>Rudan</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Salomaa</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Heinrich</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Campbell</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Price</surname>
<given-names>JF</given-names>
</string-name>, <string-name>
<surname>Karlsson</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Lind</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Micha&#x000eb;lsson</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Bandinelli</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Frayling</surname>
<given-names>TM</given-names>
</string-name>, <string-name>
<surname>Hartman</surname>
<given-names>CA</given-names>
</string-name>, <string-name>
<surname>S&#x000f8;rensen</surname>
<given-names>TI</given-names>
</string-name>, <string-name>
<surname>Kritchevsky</surname>
<given-names>SB</given-names>
</string-name>, <string-name>
<surname>Langdahl</surname>
<given-names>BL</given-names>
</string-name>, <string-name>
<surname>Eriksson</surname>
<given-names>JG</given-names>
</string-name>, <string-name>
<surname>Florez</surname>
<given-names>JC</given-names>
</string-name>, <string-name>
<surname>Spector</surname>
<given-names>TD</given-names>
</string-name>, <string-name>
<surname>Lehtim&#x000e4;ki</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Kuh</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Humphries</surname>
<given-names>SE</given-names>
</string-name>, <string-name>
<surname>Cooper</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Ohlsson</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>M&#x000e4;rz</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>de Borst</surname>
<given-names>MH</given-names>
</string-name>, <string-name>
<surname>Kumari</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Kivimaki</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>TJ</given-names>
</string-name>, <string-name>
<surname>Power</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Brenner</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Grimnes</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>van der Harst</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Snieder</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Hingorani</surname>
<given-names>AD</given-names>
</string-name>, <string-name>
<surname>Pilz</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Whittaker</surname>
<given-names>JC</given-names>
</string-name>, <string-name>
<surname>J&#x000e4;rvelin</surname>
<given-names>MR</given-names>
</string-name>, <string-name>
<surname>Hypp&#x000f6;nen</surname>
<given-names>E</given-names>
</string-name>. <article-title>Association of vitamin D status with arterial blood pressure and hypertension risk: a Mendelian randomisation study</article-title>. <source>Lancet Diabetes Endocrinol</source>. <year>2014</year>;<volume>2</volume>:<fpage>719</fpage>&#x02013;<lpage>729</lpage>.<pub-id pub-id-type="pmid">24974252</pub-id></mixed-citation></ref><ref id="jah32583-bib-0011"><label>11</label><mixed-citation publication-type="journal" id="jah32583-cit-0011">
<string-name>
<surname>Beveridge</surname>
<given-names>LA</given-names>
</string-name>, <string-name>
<surname>Struthers</surname>
<given-names>AD</given-names>
</string-name>, <string-name>
<surname>Khan</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Jorde</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Scragg</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Macdonald</surname>
<given-names>HM</given-names>
</string-name>, <string-name>
<surname>Alvarez</surname>
<given-names>JA</given-names>
</string-name>, <string-name>
<surname>Boxer</surname>
<given-names>RS</given-names>
</string-name>, <string-name>
<surname>Dalbeni</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Gepner</surname>
<given-names>AD</given-names>
</string-name>, <string-name>
<surname>Isbel</surname>
<given-names>NM</given-names>
</string-name>, <string-name>
<surname>Larsen</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Nagpal</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Petchey</surname>
<given-names>WG</given-names>
</string-name>, <string-name>
<surname>Stricker</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Strobel</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Tangpricha</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Toxqui</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Vaquero</surname>
<given-names>MP</given-names>
</string-name>, <string-name>
<surname>Wamberg</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Zittermann</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Witham</surname>
<given-names>MD</given-names>
</string-name>; <collab collab-type="authors">D&#x02010;PRESSURE Collaboration</collab>
. <article-title>Effect of vitamin D supplementation on blood pressure: a systematic review and meta&#x02010;analysis incorporating individual patient data</article-title>. <source>JAMA Intern Med</source>. <year>2015</year>;<volume>175</volume>:<fpage>745</fpage>&#x02013;<lpage>754</lpage>.<pub-id pub-id-type="pmid">25775274</pub-id></mixed-citation></ref><ref id="jah32583-bib-0012"><label>12</label><mixed-citation publication-type="journal" id="jah32583-cit-0012">
<string-name>
<surname>Upala</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Sanguankeo</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Congrete</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Jaruvongvanich</surname>
<given-names>V</given-names>
</string-name>. <article-title>Effect of cholecalciferol supplementation on arterial stiffness: a systematic review and meta&#x02010;analysis</article-title>. <source>Scand Cardiovasc J</source>. <year>2016</year>;<volume>50</volume>:<fpage>230</fpage>&#x02013;<lpage>235</lpage>.<pub-id pub-id-type="pmid">27101968</pub-id></mixed-citation></ref><ref id="jah32583-bib-0013"><label>13</label><mixed-citation publication-type="journal" id="jah32583-cit-0013">
<string-name>
<surname>Rodr&#x000ed;guez</surname>
<given-names>AJ</given-names>
</string-name>, <string-name>
<surname>Scott</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Srikanth</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Ebeling</surname>
<given-names>P</given-names>
</string-name>. <article-title>Effect of vitamin D supplementation on measures of arterial stiffness: a systematic review and meta&#x02010;analysis of randomized controlled trials</article-title>. <source>Clin Endocrinol</source>. <year>2016</year>;<volume>84</volume>:<fpage>645</fpage>&#x02013;<lpage>657</lpage>.</mixed-citation></ref><ref id="jah32583-bib-0014"><label>14</label><mixed-citation publication-type="journal" id="jah32583-cit-0014">
<string-name>
<surname>Zittermann</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Schleithoff</surname>
<given-names>SS</given-names>
</string-name>, <string-name>
<surname>Tenderich</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Berthold</surname>
<given-names>HK</given-names>
</string-name>, <string-name>
<surname>K&#x000f6;rfer</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Stehle</surname>
<given-names>P</given-names>
</string-name>. <article-title>Low vitamin D status: a contributing factor in the pathogenesis of congestive heart failure?</article-title>
<source>J Am Coll Cardiol</source>. <year>2003</year>;<volume>41</volume>:<fpage>105</fpage>&#x02013;<lpage>112</lpage>.<pub-id pub-id-type="pmid">12570952</pub-id></mixed-citation></ref><ref id="jah32583-bib-0015"><label>15</label><mixed-citation publication-type="journal" id="jah32583-cit-0015">
<string-name>
<surname>Liu</surname>
<given-names>LC</given-names>
</string-name>, <string-name>
<surname>Voors</surname>
<given-names>AA</given-names>
</string-name>, <string-name>
<surname>van Veldhuisen</surname>
<given-names>DJ</given-names>
</string-name>, <string-name>
<surname>van der Veer</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Belonje</surname>
<given-names>AM</given-names>
</string-name>, <string-name>
<surname>Szymanski</surname>
<given-names>MK</given-names>
</string-name>, <string-name>
<surname>Sillj&#x000e9;</surname>
<given-names>HH</given-names>
</string-name>, <string-name>
<surname>van Gilst</surname>
<given-names>WH</given-names>
</string-name>, <string-name>
<surname>Jaarsma</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>de Boer</surname>
<given-names>RA</given-names>
</string-name>. <article-title>Vitamin D status and outcomes in heart failure patients</article-title>. <source>Eur J Heart Fail</source>. <year>2011</year>;<volume>13</volume>:<fpage>619</fpage>&#x02013;<lpage>625</lpage>.<pub-id pub-id-type="pmid">21543375</pub-id></mixed-citation></ref><ref id="jah32583-bib-0016"><label>16</label><mixed-citation publication-type="journal" id="jah32583-cit-0016">
<string-name>
<surname>Schleithoff</surname>
<given-names>SS</given-names>
</string-name>, <string-name>
<surname>Zittermann</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Tenderich</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Berthold</surname>
<given-names>HK</given-names>
</string-name>, <string-name>
<surname>Stehle</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Koerfer</surname>
<given-names>R</given-names>
</string-name>. <article-title>Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: a double&#x02010;blind, randomized, placebo&#x02010;controlled trial</article-title>. <source>Am J Clin Nutr</source>. <year>2006</year>;<volume>83</volume>:<fpage>754</fpage>&#x02013;<lpage>759</lpage>.<pub-id pub-id-type="pmid">16600924</pub-id></mixed-citation></ref><ref id="jah32583-bib-0017"><label>17</label><mixed-citation publication-type="journal" id="jah32583-cit-0017">
<string-name>
<surname>Clarke</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Newman</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Tomson</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Hin</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Kurien</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Cox</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Lay</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Sayer</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Hill</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Emberson</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Armitage</surname>
<given-names>J</given-names>
</string-name>. <article-title>Estimation of the optimum dose of vitamin D for disease prevention in older people: rationale, design and baseline characteristics of the BEST&#x02010;D trial</article-title>. <source>Maturitas</source>. <year>2015</year>;<volume>80</volume>:<fpage>426</fpage>&#x02013;<lpage>431</lpage>.<pub-id pub-id-type="pmid">25721698</pub-id></mixed-citation></ref><ref id="jah32583-bib-0018"><label>18</label><mixed-citation publication-type="journal" id="jah32583-cit-0018">
<string-name>
<surname>Hin</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Tomson</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Newman</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Kurien</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Lay</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Cox</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Sayer</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Hill</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Emberson</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Armitage</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Clarke</surname>
<given-names>R</given-names>
</string-name>. <article-title>Optimum dose of vitamin D for disease prevention in older people. BEST&#x02010;D trial of vitamin D in primary care</article-title>. <source>Osteoporos Int</source>. <year>2016</year>;<volume>28</volume>:<fpage>841</fpage>&#x02013;<lpage>851</lpage>. Epub PMID:27986983.<pub-id pub-id-type="pmid">27986983</pub-id></mixed-citation></ref><ref id="jah32583-bib-0019"><label>19</label><mixed-citation publication-type="journal" id="jah32583-cit-0019">
<string-name>
<surname>Vlachopoulos</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Aznaouridis</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Stefanadis</surname>
<given-names>C</given-names>
</string-name>. <article-title>Prediction of cardiovascular events and all&#x02010;cause mortality with arterial stiffness: a systematic review and meta&#x02010;analysis</article-title>. <source>J Am Coll Cardiol</source>. <year>2010</year>;<volume>55</volume>:<fpage>1318</fpage>&#x02013;<lpage>1327</lpage>.<pub-id pub-id-type="pmid">20338492</pub-id></mixed-citation></ref><ref id="jah32583-bib-0020"><label>20</label><mixed-citation publication-type="journal" id="jah32583-cit-0020">
<string-name>
<surname>Ring</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Eriksson</surname>
<given-names>MJ</given-names>
</string-name>, <string-name>
<surname>Zierath</surname>
<given-names>JR</given-names>
</string-name>, <string-name>
<surname>Caidahl</surname>
<given-names>K</given-names>
</string-name>. <article-title>Arterial stiffness estimation in healthy subjects: a validation of oscillometric (Arteriograph) and tonometric (SphygmoCor) techniques</article-title>. <source>Hypertens Res</source>. <year>2014</year>;<volume>37</volume>:<fpage>999</fpage>&#x02013;<lpage>1007</lpage>.<pub-id pub-id-type="pmid">25056681</pub-id></mixed-citation></ref><ref id="jah32583-bib-0021"><label>21</label><mixed-citation publication-type="journal" id="jah32583-cit-0021">
<string-name>
<surname>Borm</surname>
<given-names>GF</given-names>
</string-name>, <string-name>
<surname>Fransen</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Lemmens</surname>
<given-names>WA</given-names>
</string-name>. <article-title>A simple formula for analysis of covariance in randomized clinical trials</article-title>. <source>J Clin Epidemiol</source>. <year>2007</year>;<volume>60</volume>:<fpage>1234</fpage>&#x02013;<lpage>1238</lpage>.<pub-id pub-id-type="pmid">17998077</pub-id></mixed-citation></ref><ref id="jah32583-bib-0022"><label>22</label><mixed-citation publication-type="book" id="jah32583-cit-0022">
<string-name>
<surname>Rubin</surname>
<given-names>DB</given-names>
</string-name>. <source>Multiple Imputation for Non&#x02010;Response in Surveys</source>. <publisher-loc>New York</publisher-loc>: <publisher-name>John Wiley</publisher-name>; <year>1987</year>.</mixed-citation></ref><ref id="jah32583-bib-0023"><label>23</label><mixed-citation publication-type="journal" id="jah32583-cit-0023">
<string-name>
<surname>Witham</surname>
<given-names>MD</given-names>
</string-name>, <string-name>
<surname>Price</surname>
<given-names>RJ</given-names>
</string-name>, <string-name>
<surname>Struthers</surname>
<given-names>AD</given-names>
</string-name>, <string-name>
<surname>Donnan</surname>
<given-names>PT</given-names>
</string-name>, <string-name>
<surname>Messow</surname>
<given-names>CM</given-names>
</string-name>, <string-name>
<surname>Ford</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>McMurdo</surname>
<given-names>ME</given-names>
</string-name>. <article-title>Cholecalciferol treatment to reduce blood pressure in older patients with isolated systolic hypertension: the VitDISH randomized controlled trial</article-title>. <source>JAMA Intern Med</source>. <year>2013</year>;<volume>173</volume>:<fpage>1672</fpage>&#x02013;<lpage>1679</lpage>.<pub-id pub-id-type="pmid">23939263</pub-id></mixed-citation></ref><ref id="jah32583-bib-0024"><label>24</label><mixed-citation publication-type="journal" id="jah32583-cit-0024">
<string-name>
<surname>Thadhani</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Appelbaum</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Pritchett</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Chang</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Wenger</surname>
<given-names>J</given-names>
</string-name>. <article-title>Vitamin D therapy and cardiac structure and function in patients with chronic kidney disease: the PRIMO randomized controlled trial</article-title>. <source>JAMA</source>. <year>2012</year>;<volume>307</volume>:<fpage>674</fpage>&#x02013;<lpage>684</lpage>.<pub-id pub-id-type="pmid">22337679</pub-id></mixed-citation></ref><ref id="jah32583-bib-0025"><label>25</label><mixed-citation publication-type="journal" id="jah32583-cit-0025">
<string-name>
<surname>Witte</surname>
<given-names>KK</given-names>
</string-name>, <string-name>
<surname>Byrom</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Gierula</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Paton</surname>
<given-names>MF</given-names>
</string-name>, <string-name>
<surname>Jamil</surname>
<given-names>HA</given-names>
</string-name>, <string-name>
<surname>Lowry</surname>
<given-names>JE</given-names>
</string-name>, <string-name>
<surname>Gillott</surname>
<given-names>RG</given-names>
</string-name>, <string-name>
<surname>Barnes</surname>
<given-names>SA</given-names>
</string-name>, <string-name>
<surname>Chumun</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Kearney</surname>
<given-names>LC</given-names>
</string-name>, <string-name>
<surname>Greenwood</surname>
<given-names>JP</given-names>
</string-name>, <string-name>
<surname>Plein</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Law</surname>
<given-names>GR</given-names>
</string-name>, <string-name>
<surname>Pavitt</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Barth</surname>
<given-names>JH</given-names>
</string-name>, <string-name>
<surname>Cubbon</surname>
<given-names>RM</given-names>
</string-name>, <string-name>
<surname>Kearney</surname>
<given-names>MT</given-names>
</string-name>. <article-title>Effects of vitamin D on cardiac function in patients with chronic HF: the VINDICATE study</article-title>. <source>J Am Coll Cardiol</source>. <year>2016</year>;<volume>67</volume>:<fpage>2593</fpage>&#x02013;<lpage>2603</lpage>.<pub-id pub-id-type="pmid">27058906</pub-id></mixed-citation></ref><ref id="jah32583-bib-0026"><label>26</label><mixed-citation publication-type="journal" id="jah32583-cit-0026">
<string-name>
<surname>Trachet</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Reymond</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Kips</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Vermeersch</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Swillens</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Stergiopulos</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Segers</surname>
<given-names>P</given-names>
</string-name>. <article-title>Validation of the Arteriograph working principle: questions still remain</article-title>. <source>J Hypertens</source>. <year>2011</year>;<volume>29</volume>:<fpage>619</fpage>.<pub-id pub-id-type="pmid">21317726</pub-id></mixed-citation></ref><ref id="jah32583-bib-0027"><label>27</label><mixed-citation publication-type="journal" id="jah32583-cit-0027">
<string-name>
<surname>Chowdhury</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Kunutsor</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Vitezova</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Oliver&#x02010;Williams</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Chowdhury</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Kiefte&#x02010;de&#x02010;Jong</surname>
<given-names>JC</given-names>
</string-name>, <string-name>
<surname>Khan</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Baena</surname>
<given-names>CP</given-names>
</string-name>, <string-name>
<surname>Prabhakaran</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Hoshen</surname>
<given-names>MB</given-names>
</string-name>, <string-name>
<surname>Feldman</surname>
<given-names>BS</given-names>
</string-name>, <string-name>
<surname>Pan</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Johnson</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Crowe</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Hu</surname>
<given-names>FB</given-names>
</string-name>, <string-name>
<surname>Franco</surname>
<given-names>OH</given-names>
</string-name>. <article-title>Vitamin D and risk of cause specific death: systematic review and meta&#x02010;analysis of observational cohort and randomised intervention studies</article-title>. <source>BMJ</source>. <year>2014</year>;<volume>348</volume>:<fpage>g1903</fpage>.<pub-id pub-id-type="pmid">24690623</pub-id></mixed-citation></ref><ref id="jah32583-bib-0028"><label>28</label><mixed-citation publication-type="journal" id="jah32583-cit-0028">
<string-name>
<surname>Bjelakovic</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Gluud</surname>
<given-names>LL</given-names>
</string-name>, <string-name>
<surname>Nikolova</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Whitfield</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Wetterslev</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Simonetti</surname>
<given-names>RG</given-names>
</string-name>, <string-name>
<surname>Bjelakovic</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Gluud</surname>
<given-names>C</given-names>
</string-name>. <article-title>Vitamin D supplementation for prevention of mortality in adults</article-title>. <source>Cochrane Database Syst Rev</source>. <year>2011</year>;(7):<fpage>CD007470</fpage> DOI: <ext-link ext-link-type="doi" xlink:href="10.1002/14651858.CD007470">10.1002/14651858.CD007470</ext-link>.<pub-id pub-id-type="pmid">21735411</pub-id></mixed-citation></ref><ref id="jah32583-bib-0029"><label>29</label><mixed-citation publication-type="journal" id="jah32583-cit-0029">
<string-name>
<surname>Ford</surname>
<given-names>JA</given-names>
</string-name>, <string-name>
<surname>MacLennan</surname>
<given-names>GS</given-names>
</string-name>, <string-name>
<surname>Avenell</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Bolland</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Grey</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Witham</surname>
<given-names>M</given-names>
</string-name>. <article-title>Cardiovascular disease and vitamin D supplementation: trial analysis, systematic review, and meta&#x02010;analysis</article-title>. <source>Am J Clin Nutr</source>. <year>2014</year>;<volume>100</volume>:<fpage>746</fpage>&#x02013;<lpage>755</lpage>.<pub-id pub-id-type="pmid">25057156</pub-id></mixed-citation></ref><ref id="jah32583-bib-0030"><label>30</label><mixed-citation publication-type="journal" id="jah32583-cit-0030">
<string-name>
<surname>Manson</surname>
<given-names>JE</given-names>
</string-name>, <string-name>
<surname>Bassuk</surname>
<given-names>SS</given-names>
</string-name>. <article-title>Vitamin D research and clinical practice: at a crossroads</article-title>. <source>JAMA</source>. <year>2015</year>;<volume>313</volume>:<fpage>1311</fpage>&#x02013;<lpage>1312</lpage>.<pub-id pub-id-type="pmid">25695911</pub-id></mixed-citation></ref><ref id="jah32583-bib-0031"><label>31</label><mixed-citation publication-type="journal" id="jah32583-cit-0031">
<string-name>
<surname>Camargo</surname>
<given-names>CA</given-names>
<suffix>Jr</suffix>
</string-name>. <article-title>Vitamin D and cardiovascular disease: time for large randomized trials</article-title>. <source>J Am Coll Cardiol</source>. <year>2011</year>;<volume>58</volume>:<fpage>1442</fpage>&#x02013;<lpage>1444</lpage>.<pub-id pub-id-type="pmid">21939826</pub-id></mixed-citation></ref><ref id="jah32583-bib-0032"><label>32</label><mixed-citation publication-type="journal" id="jah32583-cit-0032">
<string-name>
<surname>Scragg</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Stewart</surname>
<given-names>AW</given-names>
</string-name>, <string-name>
<surname>Waayer</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Lawes</surname>
<given-names>CMM</given-names>
</string-name>, <string-name>
<surname>Toop</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Sluyter</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Murphy</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Khaw</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Camargo</surname>
<given-names>CA</given-names>
</string-name>. <article-title>Effect of monthly high&#x02010;dose vitamin D supplementation on cardiovascular disease in the Vitamin D Assessment Study: a randomized clinical trial</article-title>. <source>JAMA Cardiol</source>. <year>2017</year>;<volume>2</volume>:<fpage>608</fpage>&#x02013;<lpage>616</lpage>. DOI: <ext-link ext-link-type="doi" xlink:href="10.1001/jamacardio.2017.0175">10.1001/jamacardio.2017.0175</ext-link>.<pub-id pub-id-type="pmid">28384800</pub-id></mixed-citation></ref><ref id="jah32583-bib-0033"><label>33</label><mixed-citation publication-type="journal" id="jah32583-cit-0033">
<string-name>
<surname>Ye</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Sharp</surname>
<given-names>SJ</given-names>
</string-name>, <string-name>
<surname>Burgess</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Scott</surname>
<given-names>RA</given-names>
</string-name>, <string-name>
<surname>Imamura</surname>
<given-names>F</given-names>
</string-name>; <collab collab-type="authors">InterAct Consortium</collab>
, <string-name>
<surname>Langenberg</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Wareham</surname>
<given-names>NJ</given-names>
</string-name>, <string-name>
<surname>Forouhi</surname>
<given-names>NG</given-names>
</string-name>. <article-title>Association between circulating 25&#x02010;hydroxyvitamin D and incident type 2 diabetes: a Mendelian randomisation study</article-title>. <source>Lancet Diabetes Endocrinol</source>. <year>2015</year>;<volume>3</volume>:<fpage>35</fpage>&#x02013;<lpage>42</lpage>.<pub-id pub-id-type="pmid">25281353</pub-id></mixed-citation></ref><ref id="jah32583-bib-0034"><label>34</label><mixed-citation publication-type="journal" id="jah32583-cit-0034">
<string-name>
<surname>Forouhi</surname>
<given-names>NG</given-names>
</string-name>, <string-name>
<surname>Menon</surname>
<given-names>RK</given-names>
</string-name>, <string-name>
<surname>Sharp</surname>
<given-names>SJ</given-names>
</string-name>, <string-name>
<surname>Mannan</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Timms</surname>
<given-names>PM</given-names>
</string-name>, <string-name>
<surname>Martineau</surname>
<given-names>AR</given-names>
</string-name>, <string-name>
<surname>Rickard</surname>
<given-names>AP</given-names>
</string-name>, <string-name>
<surname>Boucher</surname>
<given-names>BJ</given-names>
</string-name>, <string-name>
<surname>Chowdhury</surname>
<given-names>TA</given-names>
</string-name>, <string-name>
<surname>Griffiths</surname>
<given-names>CJ</given-names>
</string-name>, <string-name>
<surname>Greenwald</surname>
<given-names>SE</given-names>
</string-name>, <string-name>
<surname>Griffin</surname>
<given-names>SJ</given-names>
</string-name>, <string-name>
<surname>Hitman</surname>
<given-names>GA</given-names>
</string-name>. <article-title>Effects of vitamin D2 or D3 supplementation on glycaemic control and cardiometabolic risk among people at risk of type 2 diabetes: results of a randomized double&#x02010;blind placebo&#x02010;controlled trial</article-title>. <source>Diabetes Obes Metab</source>. <year>2016</year>;<volume>18</volume>:<fpage>392</fpage>&#x02013;<lpage>400</lpage>.<pub-id pub-id-type="pmid">26700109</pub-id></mixed-citation></ref><ref id="jah32583-bib-0035"><label>35</label><mixed-citation publication-type="journal" id="jah32583-cit-0035">
<string-name>
<surname>Catapano</surname>
<given-names>AL</given-names>
</string-name>, <string-name>
<surname>Graham</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>De Backer</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Wiklund</surname>
<given-names>O</given-names>
</string-name>, <string-name>
<surname>Chapman</surname>
<given-names>MJ</given-names>
</string-name>, <string-name>
<surname>Drexel</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Hoes</surname>
<given-names>AW</given-names>
</string-name>, <string-name>
<surname>Jennings</surname>
<given-names>CS</given-names>
</string-name>, <string-name>
<surname>Landmesser</surname>
<given-names>U</given-names>
</string-name>, <string-name>
<surname>Pedersen</surname>
<given-names>TR</given-names>
</string-name>, <string-name>
<surname>Reiner</surname>
<given-names>&#x0017d;</given-names>
</string-name>, <string-name>
<surname>Riccardi</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Taskinen</surname>
<given-names>MR</given-names>
</string-name>, <string-name>
<surname>Tokgozoglu</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Verschuren</surname>
<given-names>WM</given-names>
</string-name>, <string-name>
<surname>Vlachopoulos</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Wood</surname>
<given-names>DA</given-names>
</string-name>, <string-name>
<surname>Zamorano</surname>
<given-names>JL</given-names>
</string-name>. <article-title>2016 ESC/EAS guidelines for the management of dyslipidaemias: the Task Force for the Management of Dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS). Developed with the special contribution of the European Association for Cardiovascular Prevention and Rehabilitation (EACPR)</article-title>. <source>Eur Heart J</source>. <year>2016</year>;<volume>37</volume>:<fpage>2315</fpage>&#x02013;<lpage>2381</lpage>.<pub-id pub-id-type="pmid">27222591</pub-id></mixed-citation></ref></ref-list></back></article>